BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gerstein HC, Santaguida P, Raina P, Morrison KM, Balion C, Hunt D, Yazdi H, Booker L. Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies. Diabetes Res Clin Pract. 2007;78:305-312. [PMID: 17601626 DOI: 10.1016/j.diabres.2007.05.004] [Cited by in Crossref: 375] [Cited by in F6Publishing: 319] [Article Influence: 25.0] [Reference Citation Analysis]
Number Citing Articles
1 Demarsilis A, Reddy N, Boutari C, Filippaios A, Sternthal E, Katsiki N, Mantzoros C. Pharmacotherapy of type 2 diabetes: An update and future directions. Metabolism 2022;137:155332. [DOI: 10.1016/j.metabol.2022.155332] [Reference Citation Analysis]
2 Anthony N, Bruneau L, Leruste S, Franco JM, Domercq A, Kowalczyk C, Nobecourt E, Marimoutou C. Diabetes incidence in subjects with PREDIABetes from ReUNion Island: the PREDIABRUN observational cohort study protocol. BMJ Open 2022;12:e062520. [PMID: 36410808 DOI: 10.1136/bmjopen-2022-062520] [Reference Citation Analysis]
3 Carrasco-zanini J, Pietzner M, Lindbohm JV, Wheeler E, Oerton E, Kerrison N, Simpson M, Westacott M, Drolet D, Kivimaki M, Ostroff R, Williams SA, Wareham NJ, Langenberg C. Proteomic signatures for identification of impaired glucose tolerance. Nat Med 2022. [DOI: 10.1038/s41591-022-02055-z] [Reference Citation Analysis]
4 Elgart JF, Torrieri R, Ré M, Salazar M, Espeche W, Angelini JM, Martínez C, Martínez J, Giampieri C, Etchegoyen G, Ricart JP, Rodríguez ME, Gagliardino JJ. Prediabetes is more than a pre-disease: additional evidences supporting the importance of its early diagnosis and appropriate treatment. Endocrine 2022. [DOI: 10.1007/s12020-022-03249-8] [Reference Citation Analysis]
5 Chen S, Liang Y, Ye X, Zhu Z, Dong K, Liu Y, Jiang F, Wei L, Bao Y, Hou X. Effect of changes in anthropometric measurements on the remission and progression of prediabetes: a community-based cohort study. Diabetes Research and Clinical Practice 2022. [DOI: 10.1016/j.diabres.2022.110163] [Reference Citation Analysis]
6 Zandi Shafagh R, Youhanna S, Keulen J, Shen JX, Taebnia N, Preiss LC, Klein K, Büttner FA, Bergqvist M, van der Wijngaart W, Lauschke VM. Bioengineered Pancreas–Liver Crosstalk in a Microfluidic Coculture Chip Identifies Human Metabolic Response Signatures in Prediabetic Hyperglycemia. Advanced Science 2022. [DOI: 10.1002/advs.202203368] [Reference Citation Analysis]
7 Dorans KS, Bazzano LA, Qi L, He H, Chen J, Appel LJ, Chen C, Hsieh M, Hu FB, Mills KT, Nguyen BT, O’brien MJ, Samet JM, Uwaifo GI, He J. Effects of a Low-Carbohydrate Dietary Intervention on Hemoglobin A1c. JAMA Netw Open 2022;5:e2238645. [DOI: 10.1001/jamanetworkopen.2022.38645] [Reference Citation Analysis]
8 Yeung KF, Lee YQ, Chong MFF, Gandhi M, Lam AYR, Julianty S, Tan GCS, Ho ETL, Goh SY, Tan GSW, Shum EJW, Finkelstein EA, Jafar TH, van Dam RM, Teoh YL, Thumboo J, Bee YM. Baseline characteristics of participants in the Pre-Diabetes Interventions and Continued Tracking to Ease-out Diabetes (Pre-DICTED) Program. BMJ Open Diabetes Res Care 2022;10:e002966. [PMID: 36220198 DOI: 10.1136/bmjdrc-2022-002966] [Reference Citation Analysis]
9 Alizadeh Z, Baradaran HR, Kohansal K, Hadaegh F, Azizi F, Khalili D. Are the determinants of the progression to type 2 diabetes and regression to normoglycemia in the populations with pre-diabetes the same? Front Endocrinol 2022;13:1041808. [DOI: 10.3389/fendo.2022.1041808] [Reference Citation Analysis]
10 Washirasaksiri C, Srivanichakorn W, Borrisut N, Sitasuwan T, Tinmanee R, Kositamongkol C, Ariyakunaphan P, Auesomwang C, Sayabovorn N, Chaisathaphol T, Phisalprapa P. Fasting plasma glucose and HbA1c levels predict the risk of type 2 diabetes and diabetic retinopathy in a Thai high-risk population with prediabetes. Front Pharmacol 2022;13:950225. [DOI: 10.3389/fphar.2022.950225] [Reference Citation Analysis]
11 Jeem YA, Nabila R, Emelia DD, Lazuardi L, Kusnanto H. A Systematic Review and Meta-Analysis Protocol for Machine Learning Algorithms for Prediabetes Risk Calculation (Preprint).. [DOI: 10.2196/preprints.42433] [Reference Citation Analysis]
12 Gottwald-Hostalek U, Gwilt M. Vascular complications in prediabetes and type 2 diabetes: a continuous process arising from a common pathology. Curr Med Res Opin 2022;:1-30. [PMID: 35833523 DOI: 10.1080/03007995.2022.2101805] [Reference Citation Analysis]
13 Sun H, Xu L, Liu L, Zhan S, Wang S, Song Y. Predictive Efficiency of Prediabetes for Diabetes Among Chinese Middle-Aged and Older Populations: a 5-Year National Prospective Cohort Study. J Gen Intern Med 2022. [PMID: 35819686 DOI: 10.1007/s11606-022-07731-x] [Reference Citation Analysis]
14 Arranz-martínez E, Ruiz-garcía A, García Álvarez JC, Fernández Vicente T, Iturmendi Martínez N, Rivera-teijido M. Prevalence of prediabetes and association with cardiometabolic and renal factors. SIMETAP-PRED study. Clínica e Investigación en Arteriosclerosis (English Edition) 2022;34:193-204. [DOI: 10.1016/j.artere.2022.06.005] [Reference Citation Analysis]
15 Gu M, Lin Y, Gai X, Wei X, Lu C, Wang Y, Ding X, Peng Y, Ma Y. High Serum FABP4 Levels are Negatively Associated with the Reversion from Prediabetes to Normal Glucose Tolerance: A 2-Year Retrospective Cohort Community Study. DMSO 2022;Volume 15:2217-25. [DOI: 10.2147/dmso.s374912] [Reference Citation Analysis]
16 Arranz-martínez E, Ruiz-garcía A, García Álvarez JC, Fernández Vicente T, Iturmendi Martínez N, Rivera-teijido M. Prevalencia de prediabetes y asociación con factores cardiometabólicos y renales. Estudio SIMETAP-PRED. Clínica e Investigación en Arteriosclerosis 2022;34:193-204. [DOI: 10.1016/j.arteri.2021.12.002] [Reference Citation Analysis]
17 Bashkinov RA, Batluk TI, Melnikov ES, Trubnikova MA, Arutyunov AG. Influence of metabolic disorders on the development of renal pathology. jour 2022;3:7-18. [DOI: 10.21886/2712-8156-2022-3-2-7-18] [Reference Citation Analysis]
18 Özen Y, Özeke Ö, Özbay MB, Açar B, Karakurt M, Kuyumcu MS, Gayretli Yayla K, Yayla Ç, Ertem A, Aras D. İlk tanı akut koroner sendrom ile başvuran hastalarda koroner arter çaplarının prediyabet ve diyabet ile ilişkisinin incelenmesi. Turkish Journal of Clinics and Laboratory 2022. [DOI: 10.18663/tjcl.1113964] [Reference Citation Analysis]
19 Rocca-nación J, Calderon M. Cardiovascular risk, fatty liver disease, glucose and insulin curve among prediabetes phenotypes in Peruvian population. American Journal of Medicine Open 2022;7:100007. [DOI: 10.1016/j.ajmo.2022.100007] [Reference Citation Analysis]
20 Magkos F, Reeds DN, Mittendorfer B. Evolution of the diagnostic value of "the sugar of the blood": hitting the sweet spot to identify alterations in glucose dynamics. Physiological Reviews. [DOI: 10.1152/physrev.00015.2022] [Reference Citation Analysis]
21 Guariguata L, Garcia L, Sobers N, Ferguson TS, Woodcock J, Samuels TA, Guell C, Unwin N. Exploring ways to respond to rising obesity and diabetes in the Caribbean using a system dynamics model. PLOS Glob Public Health 2022;2:e0000436. [DOI: 10.1371/journal.pgph.0000436] [Reference Citation Analysis]
22 Gruß I, Mayhew M, Firemark A, Fitzpatrick SL. Participants’ perspectives on perceived usefulness of digital and in‐person diabetes prevention programs: A qualitative study to inform decisions related to program participation. Obesity Science & Practice 2022;8:176-184. [DOI: 10.1002/osp4.562] [Reference Citation Analysis]
23 Rumora A, Kim B, Feldman EL. A Role for Fatty Acids in Peripheral Neuropathy Associated with Type 2 Diabetes and Prediabetes. Antioxidants & Redox Signaling. [DOI: 10.1089/ars.2021.0155] [Reference Citation Analysis]
24 Galaviz KI, Weber MB, Suvada K, Gujral UP, Wei J, Merchant R, Dharanendra S, Haw JS, Narayan KV, Ali MK. Interventions for Reversing Prediabetes: A Systematic Review and Meta-Analysis. American Journal of Preventive Medicine 2022. [DOI: 10.1016/j.amepre.2021.10.020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
25 Burhop M, Schuchardt JP, Nebl J, Müller M, Lichtinghagen R, Hahn A. Marine Oil from C. finmarchicus Enhances Glucose Homeostasis and Liver Insulin Resistance in Obese Prediabetic Individuals. Nutrients 2022;14:396. [PMID: 35057577 DOI: 10.3390/nu14020396] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
26 Li N, Lu C, Ma Y, Wang X, Ling Y, Yin Y, Li S, Huang J, Yu L, Dong W, He H, Kang M, Ma L, Gu M, Zhao L, Huang Y, Liu F, Wang Y, Gai X, Jiang J, Peng Y, Ding X. Factors Associated with Progression of Different Prediabetic Status to Diabetes: A Community-based Cohort Study. Diabetes Res Clin Pract 2022;:109193. [PMID: 35032561 DOI: 10.1016/j.diabres.2022.109193] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Jiang Y, Jia J, Li J, Huo Y, Fan F, Zhang Y. Impaired fasting blood glucose is associated with incident albuminuria: Data from a Chinese community-based cohort. Journal of Diabetes and its Complications 2022. [DOI: 10.1016/j.jdiacomp.2022.108125] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Echouffo-Tcheugui JB, Selvin E. Prediabetes and What It Means: The Epidemiological Evidence. Annu Rev Public Health 2021;42:59-77. [PMID: 33355476 DOI: 10.1146/annurev-publhealth-090419-102644] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 24.0] [Reference Citation Analysis]
29 Raciti GA, Desiderio A, Longo M, Leone A, Zatterale F, Prevenzano I, Miele C, Napoli R, Beguinot F. DNA Methylation and Type 2 Diabetes: Novel Biomarkers for Risk Assessment? Int J Mol Sci 2021;22:11652. [PMID: 34769081 DOI: 10.3390/ijms222111652] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Lee SH, Han K, Kwon HS, Kim MK. Frequency of Exposure to Impaired Fasting Glucose and Risk of Mortality and Cardiovascular Outcomes. Endocrinol Metab (Seoul) 2021;36:1007-15. [PMID: 34674499 DOI: 10.3803/EnM.2021.1218] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
31 Wang Y, Wang L, Su Y, Zhong L, Peng B. Prediction model for the onset risk of impaired fasting glucose: a 10-year longitudinal retrospective cohort health check-up study. BMC Endocr Disord 2021;21:211. [PMID: 34686184 DOI: 10.1186/s12902-021-00878-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Lim WXJ, Gammon CS, von Hurst P, Chepulis L, Page RA. A Narrative Review of Human Clinical Trials on the Impact of Phenolic-Rich Plant Extracts on Prediabetes and Its Subgroups. Nutrients 2021;13:3733. [PMID: 34835989 DOI: 10.3390/nu13113733] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 El Fatouhi D, Héritier H, Allémann C, Malisoux L, Laouali N, Riveline JP, Salathé M, Fagherazzi G. Associations between device-measured physical activity and glycemic control and variability indices under free-living condition. Diabetes Technol Ther 2021. [PMID: 34648353 DOI: 10.1089/dia.2021.0294] [Reference Citation Analysis]
34 Benhalima K, Ma DD, Laenen A, Mathieu C, Halperin JA. Plasma glycated CD59 predicts postpartum glucose intolerance after gestational diabetes. Eur J Endocrinol 2021;185:755-63. [PMID: 34524975 DOI: 10.1530/EJE-21-0635] [Reference Citation Analysis]
35 Dicks L, Jakobs L, Sari M, Hambitzer R, Ludwig N, Simon MC, Stehle P, Stoffel-Wagner B, Helfrich HP, Ahlborn J, Rühl M, Hartmann B, Holst JJ, Ellinger S. Fortifying a meal with oyster mushroom powder beneficially affects postprandial glucagon-like peptide-1, non-esterified free fatty acids and hunger sensation in adults with impaired glucose tolerance: a double-blind randomized controlled crossover trial. Eur J Nutr 2021. [PMID: 34505919 DOI: 10.1007/s00394-021-02674-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
36 Jia Y, Liu R, Tang S, Zhang D, Wang Y, Cong L, Hou T, Ren J, Du Y. Associations of the Glycaemic Control of Diabetes with Dementia and Physical Function in Rural-Dwelling Older Chinese Adults: A Population-Based Study. Clin Interv Aging 2021;16:1503-13. [PMID: 34413638 DOI: 10.2147/CIA.S319633] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
37 Sauder KA, Ritchie ND, Crowe B, Cox E, Hudson M, Wadhwa S. Participation and weight loss in online National Diabetes Prevention Programs: a comparison of age and gender subgroups. Transl Behav Med 2021;11:342-50. [PMID: 32469058 DOI: 10.1093/tbm/ibaa048] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
38 Gagliardino JJ, Salazar MR, Espeche WG, Tolosa Chapasian PE, Gomez Garizoain D, Olano RD, Stavile RN, Balbín E, Martinez C, Leiva Sisnieguez BC, Leiva Sisnieguez CE, Carbajal HA. Arterial Stiffness: Its Relation with Prediabetes and Metabolic Syndrome and Possible Pathogenesis. J Clin Med 2021;10:3251. [PMID: 34362033 DOI: 10.3390/jcm10153251] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
39 Slurink IAL, den Braver NR, Rutters F, Kupper N, Smeets T, Elders PJM, Beulens JWJ, Soedamah-Muthu SS. Dairy product consumption and incident prediabetes in Dutch middle-aged adults: the Hoorn Studies prospective cohort. Eur J Nutr 2021. [PMID: 34245355 DOI: 10.1007/s00394-021-02626-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
40 Anthony N, Lenclume V, Fianu A, Moullec N, Debussche X, Gérardin P, Marimoutou C, Nobécourt E. Association between prediabetes definition and progression to diabetes: The REDIA follow-up study. Diabetes Epidemiology and Management 2021;3:100024. [DOI: 10.1016/j.deman.2021.100024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Barbu E, Popescu MR, Popescu AC, Balanescu SM. Phenotyping the Prediabetic Population-A Closer Look at Intermediate Glucose Status and Cardiovascular Disease. Int J Mol Sci 2021;22:6864. [PMID: 34202289 DOI: 10.3390/ijms22136864] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
42 Brown JC, Carson TL, Thompson HJ, Agurs-Collins T. The Triple Health Threat of Diabetes, Obesity, and Cancer-Epidemiology, Disparities, Mechanisms, and Interventions. Obesity (Silver Spring) 2021;29:954-9. [PMID: 34029445 DOI: 10.1002/oby.23161] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
43 Kirthi V, Perumbalath A, Brown E, Nevitt S, Petropoulos IN, Burgess J, Roylance R, Cuthbertson DJ, Jackson TL, Malik RA, Alam U. Prevalence of peripheral neuropathy in pre-diabetes: a systematic review. BMJ Open Diabetes Res Care 2021;9:e002040. [PMID: 34006607 DOI: 10.1136/bmjdrc-2020-002040] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
44 Lu Q, Wu S, Wang S, Xiao J. Influence of occupation type on the association between sleep duration and impaired fasting glucose: results from a Chinese population-based study. BMJ Open 2021;11:e042066. [PMID: 34135029 DOI: 10.1136/bmjopen-2020-042066] [Reference Citation Analysis]
45 Surampudi V, Zhou X, Tseng CH, Heber D, Li Z. Association of a Self-Paid Medically Supervised Weight Management Program with Reversal of Obesity-Associated Impaired Fasting Glucose. Clin Pract 2021;11:386-94. [PMID: 34203799 DOI: 10.3390/clinpract11020053] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Pheiffer C, Pillay-van Wyk V, Turawa E, Levitt N, Kengne AP, Bradshaw D. Prevalence of Type 2 Diabetes in South Africa: A Systematic Review and Meta-Analysis. Int J Environ Res Public Health 2021;18:5868. [PMID: 34070714 DOI: 10.3390/ijerph18115868] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
47 Bandi K, Vargas MC, Lopez A, Cameron KA, Ackermann RT, Mohr L, Williams GC, Fagerlin A, Kirley K, Hodge H, Kandula NR, O'Brien MJ. Development and Evaluation of a Prediabetes Decision Aid in Primary Care: Examining Patient-Reported Outcomes by Language Preference and Educational Attainment. Sci Diabetes Self Manag Care 2021;47:216-27. [PMID: 34000911 DOI: 10.1177/26350106211009189] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Rajput R, Garg R, Rajput M, Rani M, Darshan An V. Body composition and handgrip strength in patients with prediabetes: A case-control study from Haryana, North India. Diabetes Metab Syndr 2021;15:823-7. [PMID: 33865056 DOI: 10.1016/j.dsx.2021.03.036] [Reference Citation Analysis]
49 Kim MK, Han K, Koh ES, Hong OK, Baek KH, Song KH, Kwon HS. Cumulative exposure to impaired fasting glucose and future risk of type 2 diabetes mellitus. Diabetes Res Clin Pract 2021;175:108799. [PMID: 33845053 DOI: 10.1016/j.diabres.2021.108799] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
50 Brunetti P, Baldessin L, Pagliacci S. Prediabetes, undiagnosed diabetes and diabetes risk in Italy in 2017-2018: results from the first National screening campaign in community pharmacies. J Public Health (Oxf) 2021:fdab046. [PMID: 33837433 DOI: 10.1093/pubmed/fdab046] [Reference Citation Analysis]
51 Święcicka-Klama A, Połtyn-Zaradna K, Szuba A, Zatońska K. The Natural Course of Impaired Fasting Glucose. Adv Exp Med Biol 2021;1324:41-50. [PMID: 32767267 DOI: 10.1007/5584_2020_571] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
52 Buccheri E, Dell'Aquila D, Russo M. Artificial intelligence in health data analysis: The Darwinian evolution theory suggests an extremely simple and zero-cost large-scale screening tool for prediabetes and type 2 diabetes. Diabetes Res Clin Pract 2021;174:108722. [PMID: 33647331 DOI: 10.1016/j.diabres.2021.108722] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
53 Vasyukova OV, Okorokov PL, Peterkova VA. One-hour postload plasma glucose levels as a new criterion for assessing insulin secretion in obese children. Diabetes mellitus 2021;23:523-531. [DOI: 10.14341/dm12656] [Reference Citation Analysis]
54 Kowall B, Rathmann W, Kuss O, Herder C, Roden M, Stang A, Huth C, Thorand B, Meisinger C, Peters A. Reversion from prediabetes to normoglycaemia after weight change in older persons: The KORA F4/FF4 study. Nutr Metab Cardiovasc Dis 2021;31:429-38. [PMID: 33594985 DOI: 10.1016/j.numecd.2020.09.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
55 Dorans KS, Bazzano LA, Qi L, He H, Appel LJ, Samet JM, Chen J, Mills KT, Nguyen BT, O'Brien MJ, Uwaifo GI, He J. Low-carbohydrate dietary pattern on glycemic outcomes trial (ADEPT) among individuals with elevated hemoglobin A1c: study protocol for a randomized controlled trial. Trials 2021;22:108. [PMID: 33522954 DOI: 10.1186/s13063-020-05001-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
56 Pham DD, Lee YS, Cui S, Jeon Y, Leem CH. The mean of fasting, 1-h, and 2-h plasma glucose levels is superior to each separate index in predicting diabetes. Diabetes Res Clin Pract 2021;172:108650. [PMID: 33422588 DOI: 10.1016/j.diabres.2021.108650] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Neves JS, Correa S, Baeta Baptista R, Bigotte Vieira M, Waikar SS, Mc Causland FR. Association of Prediabetes With CKD Progression and Adverse Cardiovascular Outcomes: An Analysis of the CRIC Study. J Clin Endocrinol Metab 2020;105:dgaa017. [PMID: 31943096 DOI: 10.1210/clinem/dgaa017] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 16.0] [Reference Citation Analysis]
58 Dennison RA, Chen ES, Green ME, Legard C, Kotecha D, Farmer G, Sharp SJ, Ward RJ, Usher-Smith JA, Griffin SJ. The absolute and relative risk of type 2 diabetes after gestational diabetes: A systematic review and meta-analysis of 129 studies. Diabetes Res Clin Pract 2021;171:108625. [PMID: 33333204 DOI: 10.1016/j.diabres.2020.108625] [Cited by in Crossref: 29] [Cited by in F6Publishing: 17] [Article Influence: 14.5] [Reference Citation Analysis]
59 Xu XY, Leung AYM, Smith R, Wong JYH, Chau PH, Fong DYT. The relative risk of developing type 2 diabetes among individuals with prediabetes compared with individuals with normoglycaemia: Meta‐analysis and meta‐regression. J Adv Nurs 2020;76:3329-3345. [DOI: 10.1111/jan.14557] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
60 Eleftheriadou A, Williams S, Nevitt S, Brown E, Roylance R, Wilding JPH, Cuthbertson DJ, Alam U. The prevalence of cardiac autonomic neuropathy in prediabetes: a systematic review. Diabetologia 2021;64:288-303. [PMID: 33164108 DOI: 10.1007/s00125-020-05316-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
61 Carvalho LSF, Benseñor IM, Nogueira ACC, Duncan BB, Schmidt MI, Blaha MJ, Toth PP, Jones SR, Santos RD, Lotufo PA, Sposito AC; ELSA-Brasil study. Increased particle size of triacylglycerol-enriched remnant lipoproteins, but not their plasma concentration or lipid content, augments risk prediction of incident type 2 diabetes. Diabetologia 2021;64:385-96. [PMID: 33159534 DOI: 10.1007/s00125-020-05322-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
62 Birse CE, Shiffman D, Satish A, Fragala MS, Arellano AR, Sweet CMC, Lagier RJ. Impact of a Digital Diabetes Prevention Program on Risk Factors for Chronic Disease in a Workforce Cohort. J Occup Environ Med 2020;62:1040-5. [PMID: 33055524 DOI: 10.1097/JOM.0000000000002044] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
63 Ganie MA, Sahar T, Rashid A, Baba MS, Ahmad N, Bhat H, Wani IA, Shah ZA. Prevalence of diabetes and prediabetes in tribal population of Kashmir: Lessons for the future. Diabetes Res Clin Pract 2020;169:108457. [PMID: 32979420 DOI: 10.1016/j.diabres.2020.108457] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
64 Lv X, Yang M, Wang F, Wang Y, He X, Yi J, Wang L, Liao S. The effect of Baduanjin on intestinal flora in patients with prediabetes mellitus: Study protocol for a randomized controlled trial. Medicine (Baltimore) 2020;99:e22108. [PMID: 32925754 DOI: 10.1097/MD.0000000000022108] [Reference Citation Analysis]
65 Muche AA, Olayemi OO, Gete YK. Predictors of postpartum glucose intolerance in women with gestational diabetes mellitus: a prospective cohort study in Ethiopia based on the updated diagnostic criteria. BMJ Open 2020;10:e036882. [PMID: 32868358 DOI: 10.1136/bmjopen-2020-036882] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
66 Alogaily MH, Alsaffar AJ, Hamid MB. Left ventricle diastolic dysfunction in a sample of prediabetic adults from Baghdad, Iraq. Int J Diabetes Dev Ctries 2021;41:84-8. [DOI: 10.1007/s13410-020-00858-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
67 Minschart C, Maes T, De Block C, Van Pottelbergh I, Myngheer N, Abrams P, Vinck W, Leuridan L, Mathieu C, Billen J, Matthys C, Weyn B, Laenen A, Bogaerts A, Benhalima K. Mobile-Based Lifestyle Intervention in Women with Glucose Intolerance after Gestational Diabetes Mellitus (MELINDA), A Multicenter Randomized Controlled Trial: Methodology and Design. J Clin Med 2020;9:E2635. [PMID: 32823771 DOI: 10.3390/jcm9082635] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
68 Li Z, Wang D, Cheng Y, Chen P, Ding W, Wang Z. Association between neonatal birthweight and risk of maternal glucose intolerance after gestational diabetes mellitus. J Diabetes Investig 2021;12:425-33. [PMID: 32628808 DOI: 10.1111/jdi.13349] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
69 Wittwer JA, Golden SH, Joseph JJ. Diabetes and CVD Risk: Special Considerations in African Americans Related to Care. Curr Cardiovasc Risk Rep 2020;14. [DOI: 10.1007/s12170-020-00648-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
70 Somerville M, Burch E, Ball L, Williams LT. 'I could have made those changes years earlier': experiences and characteristics associated with receiving a prediabetes diagnosis among individuals recently diagnosed with type 2 diabetes. Fam Pract 2020;37:382-9. [PMID: 31776562 DOI: 10.1093/fampra/cmz081] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
71 Hirakawa Y, Hata J, Yoshinari M, Higashioka M, Yoshida D, Shibata M, Honda T, Sakata S, Kato H, Teramoto T, Maki H, Nishimoto S, Kitazono T, Ninomiya T. 30-minute postload plasma glucose levels during an oral glucose tolerance test predict the risk of future type 2 diabetes: the Hisayama Study. BMJ Open Diabetes Res Care 2020;8:e001156. [PMID: 32675171 DOI: 10.1136/bmjdrc-2019-001156] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
72 Chen CL, Liu L, Huang JY, Yu YL, Lo K, Huang YQ, Feng YQ. Systolic Blood Pressure, Cardiovascular Mortality, and All-Cause Mortality in Normoglycemia, Prediabetes, and Diabetes. Diabetes Metab Syndr Obes 2020;13:2375-88. [PMID: 32753922 DOI: 10.2147/DMSO.S260990] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
73 Fazli GS, Moineddin R, Chu A, Bierman AS, Booth GL. Neighborhood walkability and pre-diabetes incidence in a multiethnic population. BMJ Open Diabetes Res Care 2020;8:e000908. [PMID: 32601153 DOI: 10.1136/bmjdrc-2019-000908] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
74 Heisler M, Kullgren J, Richardson C, Stoll S, Alvarado Nieves C, Wiley D, Sedgwick T, Adams A, Hedderson M, Kim E, Rao M, Schmittdiel JA. Study protocol: Using peer support to aid in prevention and treatment in prediabetes (UPSTART). Contemp Clin Trials 2020;95:106048. [PMID: 32497783 DOI: 10.1016/j.cct.2020.106048] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
75 Werbrouck A, Schmidt M, Putman K, Annemans L, Benhalima K, Simoens S, Verhaeghe N. Cost-utility analysis of lifestyle interventions to prevent type 2 diabetes in women with prior gestational diabetes. Eur J Public Health 2020;30:473-8. [PMID: 31665267 DOI: 10.1093/eurpub/ckz196] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
76 Ntzouvani A, Antonopoulou S, Nomikos T. Effects of nut and seed consumption on markers of glucose metabolism in adults with prediabetes: a systematic review of randomised controlled trials. Br J Nutr 2019;122:361-75. [PMID: 31196252 DOI: 10.1017/S0007114519001338] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
77 Bennasar-Veny M, Fresneda S, López-González A, Busquets-Cortés C, Aguiló A, Yañez AM. Lifestyle and Progression to Type 2 Diabetes in a Cohort of Workers with Prediabetes. Nutrients 2020;12:E1538. [PMID: 32466178 DOI: 10.3390/nu12051538] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
78 Mengen E, Uçaktürk SA. Evaluation of the relationship between the one-hour plasma glucose concentration and beta-cell functions and cardiometabolic parameters during oral glucose tolerance test in obese children and adolescents. J Pediatr Endocrinol Metab 2020;33:767-75. [PMID: 32447335 DOI: 10.1515/jpem-2020-0016] [Reference Citation Analysis]
79 Wu P, Rybin D, Bielak LF, Feitosa MF, Franceschini N, Li Y, Lu Y, Marten J, Musani SK, Noordam R, Raghavan S, Rose LM, Schwander K, Smith AV, Tajuddin SM, Vojinovic D, Amin N, Arnett DK, Bottinger EP, Demirkan A, Florez JC, Ghanbari M, Harris TB, Launer LJ, Liu J, Liu J, Mook-Kanamori DO, Murray AD, Nalls MA, Peyser PA, Uitterlinden AG, Voortman T, Bouchard C, Chasman D, Correa A, de Mutsert R, Evans MK, Gudnason V, Hayward C, Kao L, Kardia SLR, Kooperberg C, Loos RJF, Province MM, Rankinen T, Redline S, Ridker PM, Rotter JI, Siscovick D, Smith BH, van Duijn C, Zonderman AB, Rao DC, Wilson JG, Dupuis J, Meigs JB, Liu CT, Vassy JL. Smoking-by-genotype interaction in type 2 diabetes risk and fasting glucose. PLoS One 2020;15:e0230815. [PMID: 32379818 DOI: 10.1371/journal.pone.0230815] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
80 Peng X, Ge J, Wang C, Sun H, Ma Q, Xu Y, Ma Y. Longitudinal Average Glucose Levels and Variance and Risk of Stroke: A Chinese Cohort Study. Int J Hypertens 2020;2020:8953058. [PMID: 32373352 DOI: 10.1155/2020/8953058] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
81 Gabriel R, Boukichou Abdelkader N, Acosta T, Gilis-Januszewska A, Gómez-Huelgas R, Makrilakis K, Kamenov Z, Paulweber B, Satman I, Djordjevic P, Alkandari A, Mitrakou A, Lalic N, Colagiuri S, Lindström J, Egido J, Natali A, Pastor JC, Teuschl Y, Lind M, Silva L, López-Ridaura R, Tuomilehto J; e-PREDICE Consortium. Early prevention of diabetes microvascular complications in people with hyperglycaemia in Europe. ePREDICE randomized trial. Study protocol, recruitment and selected baseline data. PLoS One 2020;15:e0231196. [PMID: 32282852 DOI: 10.1371/journal.pone.0231196] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
82 Lotfaliany M, Sathish T, Shaw J, Thomas E, Tapp RJ, Kapoor N, Thankappan KR, Oldenburg B. Effects of a lifestyle intervention on cardiovascular risk among high-risk individuals for diabetes in a low- and middle-income setting: Secondary analysis of the Kerala Diabetes Prevention Program. Prev Med 2020;139:106068. [PMID: 32194098 DOI: 10.1016/j.ypmed.2020.106068] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
83 Haines M. Feasibility of procedures for a randomised pilot study of reduced exertion, high-intensity interval training (REHIT) with non-diabetic hyperglycaemia patients. Pilot Feasibility Stud 2020;6:28. [PMID: 32099663 DOI: 10.1186/s40814-020-00571-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
84 Rojo-Martínez G, Valdés S, Soriguer F, Vendrell J, Urrutia I, Pérez V, Ortega E, Ocón P, Montanya E, Menéndez E, Lago-Sampedro A, González-Frutos T, Gomis R, Goday A, García-Serrano S, García-Escobar E, Galán-García JL, Castell C, Badía-Guillén R, Aguilera-Venegas G, Girbés J, Gaztambide S, Franch-Nadal J, Delgado E, Chaves FJ, Castaño L, Calle-Pascual A. Incidence of diabetes mellitus in Spain as results of the nation-wide cohort di@bet.es study. Sci Rep 2020;10:2765. [PMID: 32066839 DOI: 10.1038/s41598-020-59643-7] [Cited by in Crossref: 36] [Cited by in F6Publishing: 40] [Article Influence: 18.0] [Reference Citation Analysis]
85 Lim WXJ, Chepulis L, von Hurst P, Gammon CS, Page RA. An Acute, Placebo-Controlled, Single-Blind, Crossover, Dose-Response, Exploratory Study to Assess the Effects of New Zealand Pine Bark Extract (Enzogenol®) on Glycaemic Responses in Healthy Participants. Nutrients 2020;12:E497. [PMID: 32075228 DOI: 10.3390/nu12020497] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
86 Tsuchida K, Mitsuma W, Sato Y, Ozaki K, Soda S, Hatada K, Tanaka K, Hosaka Y, Imai S, Takahashi K, Matsubara T, Oda H. Impaired glucose tolerance and future cardiovascular risk after coronary revascularization: a 10-year follow-up report. Acta Diabetol 2020;57:173-82. [PMID: 31375898 DOI: 10.1007/s00592-019-01394-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
87 Hafez Griauzde D, Saslow L, Patterson K, Ansari T, Liestenfeltz B, Tisack A, Bihn P, Shopinski S, Richardson CR. Mixed methods pilot study of a low-carbohydrate diabetes prevention programme among adults with pre-diabetes in the USA. BMJ Open 2020;10:e033397. [PMID: 31969366 DOI: 10.1136/bmjopen-2019-033397] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
88 Falguera M, Vilanova MB, Alcubierre N, Granado-Casas M, Marsal JR, Miró N, Cebrian C, Molló À, Franch-Nadal J, Mata-Cases M, Castelblanco E, Mauricio D. Prevalence of pre-diabetes and undiagnosed diabetes in the Mollerussa prospective observational cohort study in a semi-rural area of Catalonia. BMJ Open 2020;10:e033332. [PMID: 31964673 DOI: 10.1136/bmjopen-2019-033332] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
89 Cahn A, Shoshan A, Sagiv T, Yesharim R, Goshen R, Shalev V, Raz I. Prediction of progression from pre-diabetes to diabetes: Development and validation of a machine learning model. Diabetes Metab Res Rev 2020;36:e3252. [PMID: 31943669 DOI: 10.1002/dmrr.3252] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 13.0] [Reference Citation Analysis]
90 Ammori BJ, Skarulis MC, Soran H, Syed AA, Eledrisi M, Malik RA. Medical and surgical management of obesity and diabetes: what's new? Diabet Med 2020;37:203-10. [PMID: 31850536 DOI: 10.1111/dme.14215] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
91 Almeida FA, Michaud TL, Wilson KE, Schwab RJ, Goessl C, Porter GC, Brito FA, Evans G, Dressler EV, Boggs AE, Katula JA, Sweet CC, Estabrooks PA. Preventing diabetes with digital health and coaching for translation and scalability (PREDICTS): A type 1 hybrid effectiveness-implementation trial protocol. Contemporary Clinical Trials 2020;88:105877. [DOI: 10.1016/j.cct.2019.105877] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
92 Wang L, Yang H, Huang H, Zhang C, Zuo HX, Xu P, Niu YM, Wu SS. Inulin-type fructans supplementation improves glycemic control for the prediabetes and type 2 diabetes populations: results from a GRADE-assessed systematic review and dose-response meta-analysis of 33 randomized controlled trials. J Transl Med 2019;17:410. [PMID: 31805963 DOI: 10.1186/s12967-019-02159-0] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 10.0] [Reference Citation Analysis]
93 Hu Z, Zhu X, Kaminga AC, Xu H. Associated risk factors and their interactions with type 2 diabetes among the elderly with prediabetes in rural areas of Yiyang City: A nested case-control study. Medicine (Baltimore) 2019;98:e17736. [PMID: 31689819 DOI: 10.1097/MD.0000000000017736] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
94 Kim JY, Tfayli H, Bacha F, Lee S, Michaliszyn SF, Yousuf S, Gebara N, Arslanian S. β‐cell function, incretin response, and insulin sensitivity of glucose and fat metabolism in obese youth: Relationship to OGTT‐time‐to‐glucose‐peak. Pediatr Diabetes 2020;21:18-27. [DOI: 10.1111/pedi.12940] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
95 Ramírez-Vélez R, Pérez-Sousa MÁ, González-Ruíz K, Cano-Gutierrez CA, Schmidt-RioValle J, Correa-Rodríguez M, Izquierdo M, Romero-García JA, Campos-Rodríguez AY, Triana-Reina HR, González-Jiménez E. Obesity- and Lipid-Related Parameters in the Identification of Older Adults with a High Risk of Prediabetes According to the American Diabetes Association: An Analysis of the 2015 Health, Well-Being, and Aging Study. Nutrients 2019;11:E2654. [PMID: 31689977 DOI: 10.3390/nu11112654] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 8.0] [Reference Citation Analysis]
96 Hafez D, Heisler M, Choi H, Ankuda CK, Winkelman T, Kullgren JT. Association Between Purpose in Life and Glucose Control Among Older Adults. Ann Behav Med 2018;52:309-18. [PMID: 30084896 DOI: 10.1093/abm/kax012] [Cited by in Crossref: 23] [Cited by in F6Publishing: 28] [Article Influence: 7.7] [Reference Citation Analysis]
97 Ravikumar R, S. N GK, T. AK, Kulkarni A, Magaji B, Sujive G. STUDY OF DYSLIPIDAEMIA AMONG PRE-DIABETIC PATIENTS. jebmh 2019;6:2480-2484. [DOI: 10.18410/jebmh/2019/509] [Reference Citation Analysis]
98 Wasserman DH, Wang TJ, Brown NJ. The Vasculature in Prediabetes. Circ Res 2018;122:1135-50. [PMID: 29650631 DOI: 10.1161/CIRCRESAHA.118.311912] [Cited by in Crossref: 64] [Cited by in F6Publishing: 66] [Article Influence: 21.3] [Reference Citation Analysis]
99 Hetta HF, Fahmy EM, Mohamed GA, Gaber MA, Elkady A, Elbadr MM, Al-Kadmy IMS. Does vitamin D status correlate with insulin resistance in obese prediabetic patients? An Egyptian multicenter study. Diabetes Metab Syndr 2019;13:2813-7. [PMID: 31425941 DOI: 10.1016/j.dsx.2019.07.043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
100 Rathore R, Sonwane BP, Jagadeeshaprasad MG, Kahar S, Santhakumari B, Unnikrishnan AG, Kulkarni MJ. Glycation of glucose sensitive lysine residues K36, K438 and K549 of albumin is associated with prediabetes. J Proteomics 2019;208:103481. [PMID: 31394310 DOI: 10.1016/j.jprot.2019.103481] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
101 Mahat RK, Singh N, Arora M, Rathore V. Health risks and interventions in prediabetes: A review. Diabetes Metab Syndr 2019;13:2803-11. [PMID: 31405710 DOI: 10.1016/j.dsx.2019.07.041] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
102 Gamston CE, Kirby AN, Hansen RA, Redden DT, Whitley HP, Hanson C, Lloyd KB. Description of a pharmacist-led diabetes prevention service within an employer-based wellness program. J Am Pharm Assoc (2003) 2019;59:736-41. [PMID: 31311759 DOI: 10.1016/j.japh.2019.05.023] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
103 Kumar R, Singh AK, Gupta A, Bishayee A, Pandey AK. Therapeutic potential of Aloe vera—A miracle gift of nature. Phytomedicine 2019;60:152996. [DOI: 10.1016/j.phymed.2019.152996] [Cited by in Crossref: 60] [Cited by in F6Publishing: 62] [Article Influence: 20.0] [Reference Citation Analysis]
104 Diurlin S, Eriksson MCM, Daka B, Lindblad U, Hellgren M. Men with impaired glucose tolerance have lower self-rated health than men with impaired fasting glucose. Prim Care Diabetes 2020;14:40-6. [PMID: 31204262 DOI: 10.1016/j.pcd.2019.05.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
105 Shang Y, Marseglia A, Fratiglioni L, Welmer AK, Wang R, Wang HX, Xu W. Natural history of prediabetes in older adults from a population-based longitudinal study. J Intern Med 2019;286:326-40. [PMID: 31165572 DOI: 10.1111/joim.12920] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 8.7] [Reference Citation Analysis]
106 Fazli GS, Moineddin R, Bierman AS, Booth GL. Ethnic differences in prediabetes incidence among immigrants to Canada: a population-based cohort study. BMC Med 2019;17:100. [PMID: 31122233 DOI: 10.1186/s12916-019-1337-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
107 Van Cauwenberg J, Dunstan D, Cerin E, Koohsari MJ, Sugiyama T, Owen N. Population density is beneficially associated with 12-year diabetes risk marker change among residents of lower socio-economic neighborhoods. Health & Place 2019;57:74-81. [DOI: 10.1016/j.healthplace.2019.02.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
108 Whitley HP, Hanson C, Parton JM, Smith WD. Rationale of family medicine physicians in effectively identifying patients with chronic hyperglycemia through point-of-care hemoglobin A1C screenings. J Diabetes Metab Disord 2019;18:155-62. [PMID: 31275886 DOI: 10.1007/s40200-019-00402-5] [Reference Citation Analysis]
109 Barry E, Finnikin S. A borderline HBA1c result. BMJ 2019;365:l1361. [PMID: 30975710 DOI: 10.1136/bmj.l1361] [Reference Citation Analysis]
110 Bakiner OS, Bozkırlı E, Aksöyek A, Özşahin AK. Prediabetes: An Update and a Rational for Diagnostic Confusion. Turkish Journal of Family Medicine and Primary Care 2019. [DOI: 10.21763/tjfmpc.528045] [Reference Citation Analysis]
111 Benhalima K, Van Crombrugge P, Moyson C, Verhaeghe J, Vandeginste S, Verlaenen H, Vercammen C, Maes T, Dufraimont E, De Block C, Jacquemyn Y, Mekahli F, De Clippel K, Van Den Bruel A, Loccufier A, Laenen A, Minschart C, Devlieger R, Mathieu C. Prediction of Glucose Intolerance in Early Postpartum in Women with Gestational Diabetes Mellitus Based on the 2013 WHO Criteria. J Clin Med 2019;8:E383. [PMID: 30893935 DOI: 10.3390/jcm8030383] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
112 Nesti L, Mengozzi A, Tricò D. Impact of Nutrient Type and Sequence on Glucose Tolerance: Physiological Insights and Therapeutic Implications. Front Endocrinol (Lausanne) 2019;10:144. [PMID: 30906282 DOI: 10.3389/fendo.2019.00144] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]
113 Tricò D, Galderisi A, Mari A, Santoro N, Caprio S. One-hour post-load plasma glucose predicts progression to prediabetes in a multi-ethnic cohort of obese youths. Diabetes Obes Metab 2019;21:1191-8. [PMID: 30663201 DOI: 10.1111/dom.13640] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
114 Mavrogianni C, Lambrinou CP, Androutsos O, Lindström J, Kivelä J, Cardon G, Huys N, Tsochev K, Iotova V, Chakarova N, Rurik I, Moreno LA, Liatis S, Makrilakis K, Manios Y; Feel4Diabetes-study group. Evaluation of the Finnish Diabetes Risk Score as a screening tool for undiagnosed type 2 diabetes and dysglycaemia among early middle-aged adults in a large-scale European cohort. The Feel4Diabetes-study. Diabetes Res Clin Pract 2019;150:99-110. [PMID: 30796939 DOI: 10.1016/j.diabres.2019.02.017] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
115 Yang CY, Li HY, Sung FC, Tan EC, Wei JN, Chuang LM. Relationship between fasting plasma glucose and incidence of diabetes in children and adolescents. Diabet Med 2019;36:633-43. [PMID: 30723961 DOI: 10.1111/dme.13925] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
116 Tsuboi A, Minato S, Yano M, Takeuchi M, Kitaoka K, Kurata M, Yoshino G, Wu B, Kazumi T, Fukuo K. Higher circulating adiponectin and lower orosomucoid were associated with postload glucose ≤70 mg/dL, a possible inverse marker for dysglycemia, in young Japanese women. BMJ Open Diabetes Res Care 2019;7:e000596. [PMID: 30899529 DOI: 10.1136/bmjdrc-2018-000596] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
117 Lee PC, Tan HC, Pasupathy S, Ganguly S, Eng AKH, Nadkarni N, Tham KW. Effectiveness of bariatric surgery in diabetes prevention in high-risk Asian individuals. Singapore Med J 2018;59:472-5. [PMID: 30310918 DOI: 10.11622/smedj.2018110] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
118 Shi L, Feng L, Yang Y, Li X, Zhang M, Zhang Y, Ni Q. Prevention of type 2 diabetes mellitus with acupuncture: Protocol for a systematic review and meta-analysis. Medicine (Baltimore) 2018;97:e13355. [PMID: 30508926 DOI: 10.1097/MD.0000000000013355] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
119 Alhassan Z, Budgen D, Alessa A, Alshammari R, Daghstani T, Al Moubayed N. Collaborative Denoising Autoencoder for High Glycated Haemoglobin Prediction. Artificial Neural Networks and Machine Learning – ICANN 2019: Workshop and Special Sessions 2019. [DOI: 10.1007/978-3-030-30493-5_34] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
120 Kharb S, Goel K, Rajput R. Association of Vitamin D levels with blood pressure changes and mean arterial pressure in prediabetics. Biomed Biotechnol Res J 2019;3:253. [DOI: 10.4103/bbrj.bbrj_85_19] [Reference Citation Analysis]
121 Ali MK, Shah MK, Moin T. Diabetes Management in the United States. The Diabetes Textbook 2019. [DOI: 10.1007/978-3-030-11815-0_17] [Reference Citation Analysis]
122 Gregg EW, Bracco P. The Dynamics of Diabetes Prevalence, Morbidity, and Mortality. The Diabetes Textbook 2019. [DOI: 10.1007/978-3-030-11815-0_2] [Reference Citation Analysis]
123 Rajput R, Garg K, Rajput M. Prediabetes Risk Evaluation Scoring System [PRESS]: A simplified scoring system for detecting undiagnosed Prediabetes. Prim Care Diabetes 2019;13:11-5. [PMID: 30545792 DOI: 10.1016/j.pcd.2018.11.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
124 Park SK, Ryoo J, Oh C, Choi J, Choi Y, Lee KO, Jung JY. The risk of type 2 diabetes mellitus according to 2-h plasma glucose level: The Korean Genome and Epidemiology Study (KoGES). Diabetes Research and Clinical Practice 2018;146:130-7. [DOI: 10.1016/j.diabres.2017.08.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
125 Srivanichakorn W, Godsland IF, Washirasaksiri C, Phisalprapa P, Charatcharoenwitthaya P, Pramyothin P, Sitasuwan T, Preechasuk L, Elkeles R, Alberti KGM, Johnston DG, Oliver NS. Cardiometabolic risk factors in Thai individuals with prediabetes treated in a high-risk, prevention clinic: Unexpected relationship between high-density lipoprotein cholesterol and glycemia in men. J Diabetes Investig 2019;10:771-9. [PMID: 30387292 DOI: 10.1111/jdi.12967] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
126 Lee J, Lee YA, Kim JH, Lee SY, Shin CH, Yang SW. Discrepancies between Glycosylated Hemoglobin and Fasting Plasma Glucose for Diagnosing Impaired Fasting Glucose and Diabetes Mellitus in Korean Youth and Young Adults. Diabetes Metab J 2019;43:174-82. [PMID: 30398041 DOI: 10.4093/dmj.2018.0046] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
127 Braga T, Kraemer-Aguiar LG, Docherty NG, Le Roux CW. Treating prediabetes: why and how should we do it? Minerva Med 2019;110:52-61. [PMID: 30371047 DOI: 10.23736/S0026-4806.18.05897-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
128 Ustulin M, Rhee SY, Chon S, Ahn KK, Lim JE, Oh B, Kim SH, Baik SH, Park Y, Nam MS, Lee KW, Kim YS, Woo JT. Importance of family history of diabetes in computing a diabetes risk score in Korean prediabetic population. Sci Rep 2018;8:15958. [PMID: 30374195 DOI: 10.1038/s41598-018-34411-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
129 Richter B, Hemmingsen B, Metzendorf MI, Takwoingi Y. Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia.Cochrane Database Syst Rev. 2018;10:CD012661. [PMID: 30371961 DOI: 10.1002/14651858.CD012661.pub2] [Cited by in Crossref: 34] [Cited by in F6Publishing: 57] [Article Influence: 8.5] [Reference Citation Analysis]
130 Takeuchi M, Minato S, Kitaoka K, Tsuboi A, Kurata M, Kazumi T, Fukuo K. Higher Fasting and Postprandial Free Fatty Acid Levels Are Associated With Higher Muscle Insulin Resistance and Lower Insulin Secretion in Young Non-Obese Women. J Clin Med Res 2018;10:822-9. [PMID: 30344817 DOI: 10.14740/jocmr3534w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
131 Gray LJ, Willis A, Webb D, Davies MJ, Khunti K. Screening for Diabetes and Prediabetes. In: Bonora E, Defronzo RA, editors. Diabetes Epidemiology, Genetics, Pathogenesis, Diagnosis, Prevention, and Treatment. Cham: Springer International Publishing; 2018. pp. 369-400. [DOI: 10.1007/978-3-319-45015-5_12] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
132 Jaeger A, Zollinger L, Saely CH, Muendlein A, Evangelakos I, Nasias D, Charizopoulou N, Schofield JD, Othman A, Soran H, Kardassis D, Drexel H, Eckardstein AV. Circulating microRNAs -192 and -194 are associated with the presence and incidence of diabetes mellitus. Sci Rep. 2018;8:14274. [PMID: 30250222 DOI: 10.1038/s41598-018-32274-9] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 7.5] [Reference Citation Analysis]
133 Stepanek L, Horakova D, Nakladalova M, Cibickova L, Karasek D, Zadrazil J. Significance of prediabetes as a nosological entity. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2018. [PMID: 30255857 DOI: 10.5507/bp.2018.057] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
134 Moin T, Damschroder LJ, AuYoung M, Maciejewski ML, Havens K, Ertl K, Vasti E, Weinreb JE, Steinle NI, Billington CJ, Hughes M, Makki F, Youles B, Holleman RG, Kim HM, Kinsinger LS, Richardson CR. Results From a Trial of an Online Diabetes Prevention Program Intervention. Am J Prev Med 2018;55:583-91. [PMID: 30262149 DOI: 10.1016/j.amepre.2018.06.028] [Cited by in Crossref: 46] [Cited by in F6Publishing: 50] [Article Influence: 11.5] [Reference Citation Analysis]
135 Echouffo-Tcheugui JB, Kengne AP, Ali MK. Issues in Defining the Burden of Prediabetes Globally. Curr Diab Rep 2018;18:105. [PMID: 30229351 DOI: 10.1007/s11892-018-1089-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
136 Bowen ME, Schmittdiel JA, Kullgren JT, Ackermann RT, O'Brien MJ. Building Toward a Population-Based Approach to Diabetes Screening and Prevention for US Adults. Curr Diab Rep 2018;18:104. [PMID: 30229480 DOI: 10.1007/s11892-018-1090-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
137 Mangan A, Docherty NG, Le Roux CW, Al-Najim W. Current and emerging pharmacotherapy for prediabetes: are we moving forward? Expert Opin Pharmacother 2018;19:1663-73. [PMID: 30198813 DOI: 10.1080/14656566.2018.1517155] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
138 Jensen AV, Faurholt-Jepsen D, Egelund GB, Andersen SB, Petersen PT, Benfield T, Witzenrath M, Rohde G, Ravn P; German Community-Acquired Pneumonia Competence Network (CAPNETZ)., German Community-Acquired Pneumonia Competence Network (CAPNETZ). Undiagnosed Diabetes Mellitus in Community-Acquired Pneumonia: A Prospective Cohort Study. Clin Infect Dis 2017;65:2091-8. [PMID: 29095981 DOI: 10.1093/cid/cix703] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
139 Zhang W, Yang X, Han P, Ma Y, Fu L, Jia L, Yu H, Chen X, Wang L, Hou L, Yu X, Kohzuki M, Guo Q. Risk factors for developing diabetes after 3 years among community-dwelling elderly with impaired fasting glucose: Risk factors for developing diabetes. Journal of Diabetes 2019;11:107-14. [DOI: 10.1111/1753-0407.12816] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
140 Kleinherenbrink W, Osei E, den Hertog HM, Zandbergen AAM. Prediabetes and macrovascular disease: Review of the association, influence on outcome and effect of treatment. Eur J Intern Med 2018;55:6-11. [PMID: 30007840 DOI: 10.1016/j.ejim.2018.07.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
141 Rabijewski M, Papierska L, Maksym R, Tomasiuk R, Kajdy A, Siekierski BP. The Relationship Between Health-Related Quality of Life and Anabolic Hormone Levels in Middle-Aged and Elderly Men With Prediabetes: A Cross-Sectional Study. Am J Mens Health 2018;12:1593-603. [PMID: 29882445 DOI: 10.1177/1557988318777926] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
142 Onishi Y, Hayashi T, Sato KK, Leonetti DL, Kahn SE, Fujimoto WY, Boyko EJ. Natural history of impaired glucose tolerance in Japanese Americans: Change in visceral adiposity is associated with remission from impaired glucose tolerance to normal glucose tolerance. Diabetes Res Clin Pract 2018;142:303-11. [PMID: 29859271 DOI: 10.1016/j.diabres.2018.05.045] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
143 Gilmer T, O'Connor PJ, Schiff JS, Taylor G, Vazquez-Benitez G, Garrett JE, Vue-Her H, Rinn S, Anderson J, Desai J. Cost-Effectiveness of a Community-Based Diabetes Prevention Program with Participation Incentives for Medicaid Beneficiaries. Health Serv Res 2018;53:4704-24. [PMID: 29770445 DOI: 10.1111/1475-6773.12973] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
144 Kim KY, Park JS. Impact of fish consumption by subjects with prediabetes on the metabolic risk factors: using data in the 2015 (6th) Korea National Health and Nutrition Examination Surveys. Nutr Res Pract 2018;12:233-42. [PMID: 29854329 DOI: 10.4162/nrp.2018.12.3.233] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
145 Jølle A, Åsvold BO, Holmen J, Carlsen SM, Tuomilehto J, Bjørngaard JH, Midthjell K. Basic lifestyle advice to individuals at high risk of type 2 diabetes: a 2-year population-based diabetes prevention study. The DE-PLAN intervention in the HUNT Study, Norway. BMJ Open Diabetes Res Care 2018;6:e000509. [PMID: 29765613 DOI: 10.1136/bmjdrc-2018-000509] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
146 Tsuboi A, Minato S, Yano M, Takeuchi M, Kitaoka K, Kurata M, Yoshino G, Wu B, Kazumi T, Fukuo K. Association of serum orosomucoid with 30-min plasma glucose and glucose excursion during oral glucose tolerance tests in non-obese young Japanese women. BMJ Open Diabetes Res Care 2018;6:e000508. [PMID: 29732164 DOI: 10.1136/bmjdrc-2018-000508] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
147 Liu Y, Liu FJ, Guan ZC, Dong FT, Cheng JH, Gao YP, Li D, Yan J, Liu CH, Han DP, Ma CM, Feng JN, Shen BF, Yang G. The extracellular domain of Staphylococcus aureus LtaS binds insulin and induces insulin resistance during infection. Nat Microbiol 2018;3:622-31. [PMID: 29662128 DOI: 10.1038/s41564-018-0146-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
148 Torres-salvador PD, Malaza GG, Mercado-asis LB. Correlation of Glycosylated Hemoglobin And Oral Glucose Tolerance Test Results In Hyperinsulinemic Pre-Impaired Glucose Tolerance State Versus Normoinsulinemic-Normal OGTT. jmust 2018;2:155-159. [DOI: 10.35460/2546-1621.2017-0042] [Reference Citation Analysis]
149 Sangrós FJ, Torrecilla J, Giráldez-garcía C, Carrillo L, Mancera J, Mur T, Franch J, Díez J, Goday A, Serrano R, García-soidán FJ, Cuatrecasas G, Igual D, Moreno A, Millaruelo JM, Carramiñana F, Ruiz MA, Pérez FC, Iriarte Y, Lorenzo Á, González M, Álvarez B, Barutell L, Mayayo MS, del Castillo M, Navarro E, Malo F, Cambra A, López R, Gutiérrez MÁ, Gutiérrez L, Boente C, Mediavilla JJ, Prieto L, Mendo L, Mansilla MJ, Ortega FJ, Borras A, Sánchez LG, Obaya JC, Alonso M, García F, Gutiérrez ÁT, Hernández AM, Suárez D, Álvarez JC, Sáenz I, Martínez FJ, Casorrán A, Ripoll J, Salanova A, Marín MT, Gutiérrez F, Innerárity J, Álvarez MDM, Artola S, Bedoya MJ, Poveda S, Álvarez F, Brito MJ, Iglesias R, Paniagua F, Nogales P, Gómez Á, Rubio JF, Durán MC, Sagredo J, Gijón MT, Rollán MÁ, Pérez PP, Gamarra J, Carbonell F, García-giralda L, Antón JJ, de la Flor M, Martínez R, Pardo JL, Ruiz A, Plana R, Macía R, Villaró M, Babace C, Torres JL, Blanco C, Jurado Á, Martín JL, Navarro J, Sanz G, Colas R, Cordero B, de Castro C, Ibáñez M, Monzón A, Porta N, Gómez MDC, Llanes R, Rodríguez JJ, Granero E, Sánchez M, Martínez J, Ezkurra P, Ávila L, de la Sen C, Rodríguez A, Buil P, Gabriel P, Roura P, Tarragó E, Mundet X, Bosch R, González JC, Bobé MI, Mata M, Ruiz I, López F, Birules M, Armengol O, de Miguel RM, Romera L, Benito B, Piulats N, Bilbeny B, Cabré JJ, Cos X, Pujol R, Seguí M, Losada C, de Santiago AM, Muñoz P, Regidor E. Asociación de obesidad general y abdominal con hipertensión, dislipemia y presencia de prediabetes en el estudio PREDAPS. Revista Española de Cardiología 2018;71:170-7. [DOI: 10.1016/j.recesp.2017.04.010] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 6.3] [Reference Citation Analysis]
150 Ali MK, Bullard KM, Saydah S, Imperatore G, Gregg EW. Cardiovascular and renal burdens of prediabetes in the USA: analysis of data from serial cross-sectional surveys, 1988-2014. Lancet Diabetes Endocrinol. 2018;6:392-403. [PMID: 29500121 DOI: 10.1016/S2213-8587(18)30027-5] [Cited by in Crossref: 103] [Cited by in F6Publishing: 87] [Article Influence: 25.8] [Reference Citation Analysis]
151 Jung JY, Oh C, Ryoo J, Choi J, Choi Y, Ham WT, Park SK. The influence of prehypertension, hypertension, and glycated hemoglobin on the development of type 2 diabetes mellitus in prediabetes: the Korean Genome and Epidemiology Study (KoGES). Endocrine 2018;59:593-601. [DOI: 10.1007/s12020-018-1530-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
152 Ranasinghe P, Galappatthy P, Katulanda P, Jayawardena R, Pathiranage C, Lionel A, Constantine G. Pharmacokinetics of zinc in pre-diabetes: a pilot study. jdmdc 2018;5. [DOI: 10.15406/jdmdc.2018.05.00131] [Reference Citation Analysis]
153 Echouffo-Tcheugui JB, Prorok PC. Considerations in the design of randomized trials to screen for type 2 diabetes. Clin Trials 2014;11:284-91. [PMID: 24459176 DOI: 10.1177/1740774513517062] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
154 Lao XQ, Deng HB, Liu X, Chan TC, Zhang Z, Chang LY, Yeoh EK, Tam T, Wong MCS, Thomas GN. Increased leisure-time physical activity associated with lower onset of diabetes in 44 828 adults with impaired fasting glucose: a population-based prospective cohort study. Br J Sports Med 2019;53:895-900. [PMID: 29331993 DOI: 10.1136/bjsports-2017-098199] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 9.5] [Reference Citation Analysis]
155 Kengne AP. Screening Strategies for Type 2 Diabetes and Risk Stratification in Minorities. Updates in Hypertension and Cardiovascular Protection 2018. [DOI: 10.1007/978-3-319-93148-7_18] [Reference Citation Analysis]
156 Modesti PA, Calabrese M, Galanti G. Risk Assessment of Future Type 2 Diabetes and Implication for Prevention. Updates in Hypertension and Cardiovascular Protection 2018. [DOI: 10.1007/978-3-319-93148-7_17] [Reference Citation Analysis]
157 Gray LJ, Willis A, Webb D, Davies MJ, Khunti K. Screening for Diabetes and Prediabetes. Endocrinology 2018. [DOI: 10.1007/978-3-319-27317-4_12-1] [Reference Citation Analysis]
158 Ali MK, Siegel KR, Chandrasekar E, Tandon N, Montoya PA, Mbanya JC, Chan J, Zhang P, Narayan KMV. Diabetes: An Update on the Pandemic and Potential Solutions. In: Prabhakaran D, Anand S, Gaziano TA, Mbanya J, Wu Y, Nugent R, editors. Disease Control Priorities, Third Edition (Volume 5): Cardiovascular, Respiratory, and Related Disorders. The World Bank; 2017. pp. 209-34. [DOI: 10.1596/978-1-4648-0518-9_ch12] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
159 Silvestre MP, Jiang Y, Volkova K, Chisholm H, Lee W, Poppitt SD. Evaluating FINDRISC as a screening tool for type 2 diabetes among overweight adults in the PREVIEW:NZ cohort. Primary Care Diabetes 2017;11:561-9. [DOI: 10.1016/j.pcd.2017.07.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
160 Khokhar A, Umpaichitra V, Chin VL, Perez-colon S. Metformin Use in Children and Adolescents with Prediabetes. Pediatric Clinics of North America 2017;64:1341-53. [DOI: 10.1016/j.pcl.2017.08.010] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 6.0] [Reference Citation Analysis]
161 Kimball SM, Emery JCH, Lewanczuk RZ. Effect of a vitamin and mineral supplementation on glycemic status: Results from a community-based program. J Clin Transl Endocrinol 2017;10:28-35. [PMID: 29204369 DOI: 10.1016/j.jcte.2017.11.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
162 Cefalu WT. "Prediabetes": Are There Problems With This Label? No, We Need Heightened Awareness of This Condition! Diabetes Care 2016;39:1472-7. [PMID: 27457639 DOI: 10.2337/dc16-1143] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 5.4] [Reference Citation Analysis]
163 Sai Prasanna N, Amutha A, Pramodkumar TA, Anjana RM, Venkatesan U, Priya M, Pradeepa R, Mohan V. The 1 h post glucose value best predicts future dysglycemia among normal glucose tolerance subjects. Journal of Diabetes and its Complications 2017;31:1592-6. [DOI: 10.1016/j.jdiacomp.2017.07.017] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
164 Gagliardino JJ, Elgart JF, Bourgeois M, Etchegoyen G, Fantuzzi G, Ré M, Ricart JP, García S, Giampieri C, González L, Suárez-Crivaro F, Kronsbein P, Angelini JM, Martínez C, Martínez J, Ricart A, Spinedi E. Diabetes primary prevention program: New insights from data analysis of recruitment period. Diabetes Metab Res Rev 2018;34. [PMID: 28843031 DOI: 10.1002/dmrr.2943] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
165 Dolz M, Dhane Y. [Prediabetes, definition and treatment]. Soins 2017;62:11-6. [PMID: 29031374 DOI: 10.1016/j.soin.2017.08.002] [Reference Citation Analysis]
166 Weiss R, Hagman E. Pathogenesis of Insulin Resistance and Glucose Intolerance in Childhood Obesity. In: Freemark MS, editor. Pediatric Obesity. Cham: Springer International Publishing; 2018. pp. 379-91. [DOI: 10.1007/978-3-319-68192-4_23] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
167 Huang H, Liao D, Chen G, Chen H, Zhu Y. Lack of efficacy of pomegranate supplementation for glucose management, insulin levels and sensitivity: evidence from a systematic review and meta-analysis. Nutr J 2017;16:67. [PMID: 28985741 DOI: 10.1186/s12937-017-0290-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
168 Weiss R, Santoro N, Giannini C, Galderisi A, Umano GR, Caprio S. Prediabetes in youth - mechanisms and biomarkers. Lancet Child Adolesc Health 2017;1:240-8. [PMID: 29075659 DOI: 10.1016/S2352-4642(17)30044-5] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 6.2] [Reference Citation Analysis]
169 Fiorentino TV, Suraci E, Arcidiacono GP, Cimellaro A, Mignogna C, Presta I, Andreozzi F, Hribal ML, Perticone F, Donato G, Luzza F, Sesti G. Duodenal Sodium/Glucose Cotransporter 1 Expression Under Fasting Conditions Is Associated With Postload Hyperglycemia. The Journal of Clinical Endocrinology & Metabolism 2017;102:3979-89. [DOI: 10.1210/jc.2017-00348] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 4.2] [Reference Citation Analysis]
170 Yin Y, Ding X, Peng L, Hou Y, Ling Y, Gu M, Wang Y, Peng Y, Sun H. Increased Serum ANGPTL8 Concentrations in Patients with Prediabetes and Type 2 Diabetes. J Diabetes Res 2017;2017:8293207. [PMID: 29082263 DOI: 10.1155/2017/8293207] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
171 Sepah SC, Jiang L, Ellis RJ, McDermott K, Peters AL. Engagement and outcomes in a digital Diabetes Prevention Program: 3-year update. BMJ Open Diabetes Res Care 2017;5:e000422. [PMID: 28948027 DOI: 10.1136/bmjdrc-2017-000422] [Cited by in Crossref: 58] [Cited by in F6Publishing: 60] [Article Influence: 11.6] [Reference Citation Analysis]
172 Kokic V, Kokic S, Krnic M, Petric M, Liberati AM, Simac P, Milenkovic T, Capkun V, Rahelic D, Blaslov K. Prediabetes awareness among Southeastern European physicians. J Diabetes Investig 2017. [PMID: 28853223 DOI: 10.1111/jdi.12740] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
173 Cunningham SA, Adams SR, Schmittdiel JA, Ali MK. Incidence of diabetes after a partner's diagnosis. Prev Med 2017;105:52-7. [PMID: 28823754 DOI: 10.1016/j.ypmed.2017.08.020] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
174 Adams R, Hebert CJ, Mcvey L, Williams R. Implementation of the YMCA Diabetes Prevention Program throughout an Integrated Health System: A Translational Study. Perm J 2016;20:15-241. [PMID: 27828773 DOI: 10.7812/TPP/15-241] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
175 Sangrós FJ, Torrecilla J, Giráldez-García C, Carrillo L, Mancera J, Mur T, Franch J, Díez J, Goday A, Serrano R, García-Soidán FJ, Cuatrecasas G, Igual D, Moreno A, Millaruelo JM, Carramiñana F, Ruiz MA, Pérez FC, Iriarte Y, Lorenzo Á, González M, Álvarez B, Barutell L, Mayayo MS, Del Castillo M, Navarro E, Malo F, Cambra A, López R, Gutiérrez MÁ, Gutiérrez L, Boente C, Mediavilla JJ, Prieto L, Mendo L, Mansilla MJ, Ortega FJ, Borras A, Sánchez LG, Obaya JC, Alonso M, García F, Gutiérrez ÁT, Hernández AM, Suárez D, Álvarez JC, Sáenz I, Martínez FJ, Casorrán A, Ripoll J, Salanova A, Marín MT, Gutiérrez F, Innerárity J, Álvarez MDM, Artola S, Bedoya MJ, Poveda S, Álvarez F, Brito MJ, Iglesias R, Paniagua F, Nogales P, Gómez Á, Rubio JF, Durán MC, Sagredo J, Gijón MT, Rollán MÁ, Pérez PP, Gamarra J, Carbonell F, García-Giralda L, Antón JJ, de la Flor M, Martínez R, Pardo JL, Ruiz A, Plana R, Macía R, Villaró M, Babace C, Torres JL, Blanco C, Jurado Á, Martín JL, Navarro J, Sanz G, Colas R, Cordero B, de Castro C, Ibáñez M, Monzón A, Porta N, Gómez MDC, Llanes R, Rodríguez JJ, Granero E, Sánchez M, Martínez J, Ezkurra P, Ávila L, de la Sen C, Rodríguez A, Buil P, Gabriel P, Roura P, Tarragó E, Mundet X, Bosch R, González JC, Bobé MI, Mata M, Ruiz I, López F, Birules M, Armengol O, de Miguel RM, Romera L, Benito B, Piulats N, Bilbeny B, Cabré JJ, Cos X, Pujol R, Seguí M, Losada C, de Santiago AM, Muñoz P, Regidor E. Association of General and Abdominal Obesity With Hypertension, Dyslipidemia and Prediabetes in the PREDAPS Study. Rev Esp Cardiol (Engl Ed) 2018;71:170-7. [PMID: 28789915 DOI: 10.1016/j.rec.2017.04.035] [Cited by in Crossref: 10] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
176 Ruscitti P, Ursini F, Cipriani P, Liakouli V, Carubbi F, Berardicurti O, De Sarro G, Giacomelli R. Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: A 1-year, single-centre, longitudinal study. PLoS One 2017;12:e0181203. [PMID: 28704564 DOI: 10.1371/journal.pone.0181203] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 7.0] [Reference Citation Analysis]
177 Jang E, Lee J, Lee S, Kim MH. Short-Term Effect of Convenience Meal Intake on Glycemic Response and Satiety among Healthy College Students in South Korea. Clin Nutr Res 2017;6:215-20. [PMID: 28770184 DOI: 10.7762/cnr.2017.6.3.215] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
178 Albu JB, Sohler N, Li R, Li X, Young E, Gregg EW, Ross-Degnan D. An Interrupted Time Series Analysis to Determine the Effect of an Electronic Health Record-Based Intervention on Appropriate Screening for Type 2 Diabetes in Urban Primary Care Clinics in New York City. Diabetes Care 2017;40:1058-64. [PMID: 28620094 DOI: 10.2337/dc16-2133] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
179 Vilanova MB, Falguera M, Marsal JR, Rubinat E, Alcubierre N, Castelblanco E, Granado-Casas M, Miró N, Molló À, Mata-Cases M, Franch-Nadal J, Mauricio D. Prevalence, clinical features and risk assessment of pre-diabetes in Spain: the prospective Mollerussa cohort study. BMJ Open 2017;7:e015158. [PMID: 28606902 DOI: 10.1136/bmjopen-2016-015158] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
180 Feng X, Xu Y. Hyperhomocysteinemia as a Metabolic Risk Factor for Glucose Intolerance Among High-Risk Groups of Chinese Adults. Med Sci Monit 2017;23:2775-81. [PMID: 28591087 DOI: 10.12659/msm.905002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
181 Hu Z, Qin L, Xu H. One-Year Results of a Synthetic Intervention Model for the Primary Prevention of T2D among Elderly Individuals with Prediabetes in Rural China. Int J Environ Res Public Health 2017;14:E417. [PMID: 28420105 DOI: 10.3390/ijerph14040417] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
182 Hafez D, Nelson DB, Martin EG, Cohen AJ, Northway R, Kullgren JT. Understanding type 2 diabetes mellitus screening practices among primary care physicians: a qualitative chart-stimulated recall study. BMC Fam Pract 2017;18:50. [PMID: 28376802 DOI: 10.1186/s12875-017-0623-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
183 Feng X, Gao X, Yao Z, Xu Y. Low apoA-I is associated with insulin resistance in patients with impaired glucose tolerance: a cross-sectional study. Lipids Health Dis 2017;16:69. [PMID: 28372564 DOI: 10.1186/s12944-017-0446-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
184 Buysschaert M, Bergman M, Yanogo D, Jagannathan R, Buysschaert B, Preumont V. An elevated 1-h post- load glucose level during the oral glucose tolerance test detects prediabetes. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2017;11:137-9. [DOI: 10.1016/j.dsx.2016.12.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
185 Feng X, Gao X, Jia Y, Xu Y. PPAR-α Agonist Fenofibrate Reduces Insulin Resistance in Impaired Glucose Tolerance Patients with Hypertriglyceridemia: A Cross-Sectional Study. Diabetes Ther 2017;8:433-44. [PMID: 28361462 DOI: 10.1007/s13300-017-0257-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
186 Man REK, Charumathi S, Gan ATL, Fenwick EK, Tey CS, Chua J, Wong TY, Cheng CY, Lamoureux EL. Cumulative incidence and risk factors of prediabetes and type 2 diabetes in a Singaporean Malay cohort. Diabetes Res Clin Pract 2017;127:163-71. [PMID: 28371687 DOI: 10.1016/j.diabres.2017.03.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
187 Shi YL, Liu WJ, Zhang XF, Su WJ, Chen NN, Lu SH, Wang LY, Shi XL, Li ZB, Yang SY. Effect of Chinese Herbal Medicine Jinlida Granule in Treatment of Patients with Impaired Glucose Tolerance. Chin Med J (Engl) 2016;129:2281-6. [PMID: 27647185 DOI: 10.4103/0366-6999.190676] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
188 Marcovecchio ML, Bagordo M, Marisi E, de Giorgis T, Chiavaroli V, Chiarelli F, Mohn A. One-hour post-load plasma glucose levels associated with decreased insulin sensitivity and secretion and early makers of cardiometabolic risk. J Endocrinol Invest 2017;40:771-8. [DOI: 10.1007/s40618-017-0638-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 3.4] [Reference Citation Analysis]
189 Feng X, Gao X, Jia Y, Zhang H, Xu Y. Atorvastatin Decreased Circulating RANTES Levels in Impaired Glucose Tolerance Patients with Hypercholesterolemia: An Interventional Study. Diabetes Ther 2017;8:309-19. [PMID: 28120261 DOI: 10.1007/s13300-017-0227-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
190 Andersson S, Karlsson V, Bennet L, Fellbrant K, Hellgren M. Attitudes Regarding Participation in a Diabetes Screening Test among an Assyrian Immigrant Population in Sweden. Nurs Res Pract 2016;2016:1504530. [PMID: 28083149 DOI: 10.1155/2016/1504530] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
191 Park JS, Kim KY. Relationship between dairy products, fish and shellfish intake and metabolic syndrome risk factors in prediabetes: based on the sixth Korea National Health and Nutrition Examination Survey (KNHANES VI-3) 2015. J Nutr Health 2017;50:447. [DOI: 10.4163/jnh.2017.50.5.447] [Reference Citation Analysis]
192 Davies MJ, Gray LJ, Ahrabian D, Carey M, Farooqi A, Gray A, Goldby S, Hill S, Jones K, Leal J, Realf K, Skinner T, Stribling B, Troughton J, Yates T, Khunti K. A community-based primary prevention programme for type 2 diabetes mellitus integrating identification and lifestyle intervention for prevention: a cluster randomised controlled trial. Programme Grants Appl Res 2017;5:1-290. [DOI: 10.3310/pgfar05020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
193 Schröder K, Hamann A. Bewegung und Diabetes mellitus. Körperliche Aktivität und Gesundheit 2017. [DOI: 10.1007/978-3-662-50335-5_12] [Reference Citation Analysis]
194 Janghorbani M, Amini M, Aminorroaya A. Low Levels of High-Density Lipoprotein Cholesterol Do Not Predict the Incidence of Type 2 Diabetes in an Iranian High-Risk Population: The Isfahan Diabetes Prevention Study. Rev Diabet Stud 2016;13:187-96. [PMID: 28012282 DOI: 10.1900/RDS.2016.13.187] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
195 Ibrahim N, Ming Moy F, Awalludin IA, Mohd Ali Z, Ismail IS. Effects of a Community-Based Healthy Lifestyle Intervention Program (Co-HELP) among Adults with Prediabetes in a Developing Country: A Quasi-Experimental Study. PLoS One 2016;11:e0167123. [PMID: 27935988 DOI: 10.1371/journal.pone.0167123] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 4.2] [Reference Citation Analysis]
196 Ali MK, Galaviz KI, Weber MB, Narayan KV. The Global Burden of Diabetes. In: Holt RIG, Cockram CS, Flyvbjerg A, Goldstein BJ, editors. Textbook of Diabetes. Chichester: John Wiley & Sons, Ltd; 2017. pp. 65-83. [DOI: 10.1002/9781118924853.ch5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
197 Rezaei M, Hosseinsabet A. Assessment of atrial conduction times in prediabetic patients with coronary artery disease. Anatol J Cardiol 2017;17:374-80. [PMID: 27965511 DOI: 10.14744/AnatolJCardiol.2016.7396] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
198 Graham E, Au B, Schmitz N. Depressive symptoms, prediabetes, and incident diabetes in older English adults. Int J Geriatr Psychiatry 2017;32:1450-8. [PMID: 27892613 DOI: 10.1002/gps.4634] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
199 Bergman M, Chetrit A, Roth J, Jagannathan R, Sevick M, Dankner R. One-hour post-load plasma glucose level during the OGTT predicts dysglycemia. Diabetes Research and Clinical Practice 2016;120:221-8. [DOI: 10.1016/j.diabres.2016.08.013] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 6.5] [Reference Citation Analysis]
200 DeJesus RS, Breitkopf CR, Rutten LJ, Jacobson DJ, Wilson PM, Sauver JS. Incidence Rate of Prediabetes Progression to Diabetes: Modeling an Optimum Target Group for Intervention. Popul Health Manag 2017;20:216-23. [PMID: 27689627 DOI: 10.1089/pop.2016.0067] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 4.2] [Reference Citation Analysis]
201 O'Brien MJ, Moran MR, Tang JW, Vargas MC, Talen M, Zimmermann LJ, Ackermann RT, Kandula NR. Patient Perceptions About Prediabetes and Preferences for Diabetes Prevention. Diabetes Educ 2016;42:667-77. [PMID: 27621093 DOI: 10.1177/0145721716666678] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 4.8] [Reference Citation Analysis]
202 Aguayo A, Urrutia I, González-Frutos T, Martínez R, Martínez-Indart L, Castaño L, Gaztambide S; Diabetes Epidemiology Basque Study Group. Prevalence of diabetes mellitus and impaired glucose metabolism in the adult population of the Basque Country, Spain. Diabet Med 2017;34:662-6. [PMID: 27353285 DOI: 10.1111/dme.13181] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
203 Wolever TMS, van Klinken BJ, Spruill SE, Jenkins AL, Chu Y, Harkness L. Effect of serving size and addition of sugar on the glycemic response elicited by oatmeal: A randomized, cross-over study. Clin Nutr ESPEN 2016;16:48-54. [PMID: 28531455 DOI: 10.1016/j.clnesp.2016.07.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
204 Hagman E, Danielsson P, Brandt L, Ekbom A, Marcus C. Association between impaired fasting glycaemia in pediatric obesity and type 2 diabetes in young adulthood. Nutr Diabetes 2016;6:e227. [PMID: 27548712 DOI: 10.1038/nutd.2016.34] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 5.2] [Reference Citation Analysis]
205 Vassallo P, Driver SL, Stone NJ. Metabolic Syndrome: An Evolving Clinical Construct. Prog Cardiovasc Dis 2016;59:172-7. [PMID: 27497505 DOI: 10.1016/j.pcad.2016.07.012] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
206 Kim KY, Yun JM, Yang SJ. Consumption of Dairy Foods and Risk of Pre-Diabetes in Subjects that Visited Health Examination Center in Gwangju. Journal of the Korean Society of Food Science and Nutrition 2016;45:1049-1056. [DOI: 10.3746/jkfn.2016.45.7.1049] [Reference Citation Analysis]
207 Mudaliar U, Zabetian A, Goodman M, Echouffo-Tcheugui JB, Albright AL, Gregg EW, Ali MK. Cardiometabolic Risk Factor Changes Observed in Diabetes Prevention Programs in US Settings: A Systematic Review and Meta-analysis. PLoS Med 2016;13:e1002095. [PMID: 27459705 DOI: 10.1371/journal.pmed.1002095] [Cited by in Crossref: 90] [Cited by in F6Publishing: 91] [Article Influence: 15.0] [Reference Citation Analysis]
208 Yang HK, Ha HS, Rhee M, Lee JH, Park YM, Kwon HS, Yim HW, Kang MI, Lee WC, Son HY, Lee SH, Yoon KH. Predictive Value of Glucose Parameters Obtained From Oral Glucose Tolerance Tests in Identifying Individuals at High Risk for the Development of Diabetes in Korean Population. Medicine (Baltimore) 2016;95:e3053. [PMID: 26962830 DOI: 10.1097/MD.0000000000003053] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
209 Ali MK, Narayan KM. Screening for Dysglycemia: Connecting Supply and Demand to Slow Growth in Diabetes Incidence. PLoS Med 2016;13:e1002084. [PMID: 27434726 DOI: 10.1371/journal.pmed.1002084] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
210 Brunisholz KD, Joy EA, Hashibe M, Gren LH, Savitz LA, Hamilton S, Cannon W, Kim J. Incidental Risk of Type 2 Diabetes Mellitus among Patients with Confirmed and Unconfirmed Prediabetes. PLoS One 2016;11:e0157729. [PMID: 27427913 DOI: 10.1371/journal.pone.0157729] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
211 Zimmet P, Alberti KG, Magliano DJ, Bennett PH. Diabetes mellitus statistics on prevalence and mortality: facts and fallacies. Nat Rev Endocrinol. 2016;12:616-622. [PMID: 27388988 DOI: 10.1038/nrendo.2016.105] [Cited by in Crossref: 388] [Cited by in F6Publishing: 400] [Article Influence: 64.7] [Reference Citation Analysis]
212 Scazzina F, Dei Cas A, Del Rio D, Brighenti F, Bonadonna RC. The β-cell burden index of food: A proposal. Nutr Metab Cardiovasc Dis 2016;26:872-8. [PMID: 27381989 DOI: 10.1016/j.numecd.2016.04.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
213 Kim JD, Kang SJ, Lee MK, Park SE, Rhee EJ, Park CY, Oh KW, Park SW, Lee WY. C-Peptide-Based Index Is More Related to Incident Type 2 Diabetes in Non-Diabetic Subjects than Insulin-Based Index. Endocrinol Metab (Seoul) 2016;31:320-7. [PMID: 27349701 DOI: 10.3803/EnM.2016.31.2.320] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 6.5] [Reference Citation Analysis]
214 Samson SL, Garber AJ. Prevention of type 2 Diabetes Mellitus: Potential of pharmacological agents. Best Practice & Research Clinical Endocrinology & Metabolism 2016;30:357-71. [DOI: 10.1016/j.beem.2016.06.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
215 Hong JL, McNeill AM, He J, Chen Y, Brodovicz KG. Identification of impaired fasting glucose, healthcare utilization and progression to diabetes in the UK using the Clinical Practice Research Datalink (CPRD). Pharmacoepidemiol Drug Saf 2016;25:1375-86. [PMID: 27193175 DOI: 10.1002/pds.4007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
216 Stefan N, Fritsche A, Schick F, Häring HU. Phenotypes of prediabetes and stratification of cardiometabolic risk. Lancet Diabetes Endocrinol 2016;4:789-98. [PMID: 27185609 DOI: 10.1016/S2213-8587(16)00082-6] [Cited by in Crossref: 124] [Cited by in F6Publishing: 129] [Article Influence: 20.7] [Reference Citation Analysis]
217 Meijnikman AS, De Block CE, Verrijken A, Mertens I, Corthouts B, Van Gaal LF. Screening for type 2 diabetes mellitus in overweight and obese subjects made easy by the FINDRISC score. J Diabetes Complications 2016;30:1043-9. [PMID: 27217020 DOI: 10.1016/j.jdiacomp.2016.05.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
218 Guo VY, Yu EY, Wong CKh, Sit RW, Wang JH, Ho SY, Lam CL. Validation of a nomogram for predicting regression from impaired fasting glucose to normoglycaemia to facilitate clinical decision making. Fam Pract 2016;33:401-7. [PMID: 27142313 DOI: 10.1093/fampra/cmw031] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
219 Miyake T, Kumagi T, Hirooka M, Furukawa S, Yoshida O, Koizumi M, Yamamoto S, Watanabe T, Yamamoto Y, Tokumoto Y, Takeshita E, Abe M, Kitai K, Matsuura B, Hiasa Y. Low alcohol consumption increases the risk of impaired glucose tolerance in patients with non-alcoholic fatty liver disease. J Gastroenterol 2016;51:1090-100. [PMID: 26971094 DOI: 10.1007/s00535-016-1194-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
220 Rasmussen SS, Johansen NB, Witte DR, Borch-Johnsen K, Sandbaek A, Lauritzen T, Jørgensen ME. Incidence of register-based diabetes 10 years after a stepwise diabetes screening programme: the ADDITION-Denmark study. Diabetologia 2016;59:989-97. [PMID: 26857739 DOI: 10.1007/s00125-016-3887-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
221 Eikenberg JD, Savla J, Marinik EL, Davy KP, Pownall J, Baugh ME, Flack KD, Boshra S, Winett RA, Davy BM. Prediabetes Phenotype Influences Improvements in Glucose Homeostasis with Resistance Training. PLoS One 2016;11:e0148009. [PMID: 26840904 DOI: 10.1371/journal.pone.0148009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
222 Zabulienė L, Hendrixson V, Urbonienė J, Varvuolytė S. ATRANKA DĖL DIABETO IR GLIUKOZĖS TOLERAVIMO MĖGINYS. LITERATŪROS APŽVALGA. Medicinos teorija ir praktika 2016;22:77-88. [DOI: 10.15591/mtp.2016.012] [Reference Citation Analysis]
223 Zoidis E, Papamikos V. Glucose: Glucose Intolerance. Encyclopedia of Food and Health 2016. [DOI: 10.1016/b978-0-12-384947-2.00352-4] [Reference Citation Analysis]
224 Balk EM, Earley A, Raman G, Avendano EA, Pittas AG, Remington PL. Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among Persons at Increased Risk: A Systematic Review for the Community Preventive Services Task Force. Ann Intern Med. 2015;163:437-451. [PMID: 26167912 DOI: 10.7326/m15-0452] [Cited by in Crossref: 187] [Cited by in F6Publishing: 206] [Article Influence: 26.7] [Reference Citation Analysis]
225 Zabulienė L, Pauliukienė B, Urbonienė J, Stukas R. Gliukozės toleravimo mėginio svarba kasdienėje ambulatorinėje praktikoje. Sveikatos mokslai 2015;25:94-106. [DOI: 10.5200/sm-hs.2015.095] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
226 Oka R, Aizawa T, Miyamoto S, Yoneda T, Yamagishi M. One-hour plasma glucose as a predictor of the development of Type 2 diabetes in Japanese adults. Diabet Med 2016;33:1399-405. [DOI: 10.1111/dme.12994] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
227 Ligthart S, van Herpt TT, Leening MJ, Kavousi M, Hofman A, Stricker BH, van Hoek M, Sijbrands EJ, Franco OH, Dehghan A. Lifetime risk of developing impaired glucose metabolism and eventual progression from prediabetes to type 2 diabetes: a prospective cohort study. Lancet Diabetes Endocrinol 2016;4:44-51. [PMID: 26575606 DOI: 10.1016/S2213-8587(15)00362-9] [Cited by in Crossref: 145] [Cited by in F6Publishing: 125] [Article Influence: 20.7] [Reference Citation Analysis]
228 Zendjabil M. Biological diagnosis of diabetes mellitus. Pathol Biol (Paris) 2015:S0369-8114(15)00100-5. [PMID: 26552327 DOI: 10.1016/j.patbio.2015.10.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
229 Abdelhafiz AH, Sinclair AJ. Epidemiology, aetiology, pathogenesis and management of diabetes in older people. Advanced Nutrition and Dietetics in Diabetes 2015. [DOI: 10.1002/9781119121725.ch25] [Reference Citation Analysis]
230 Modesti PA, Galanti G, Cala' P, Calabrese M. Lifestyle interventions in preventing new type 2 diabetes in Asian populations. Intern Emerg Med 2016;11:375-84. [PMID: 26475162 DOI: 10.1007/s11739-015-1325-2] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
231 Poolsup N, Suksomboon N, Plordplong N. Effect of vitamin D supplementation on insulin resistance and glycaemic control in prediabetes: a systematic review and meta-analysis. Diabet Med 2016;33:290-9. [PMID: 26308752 DOI: 10.1111/dme.12893] [Cited by in Crossref: 69] [Cited by in F6Publishing: 75] [Article Influence: 9.9] [Reference Citation Analysis]
232 Malo JA, Versace VL, Janus ED, Laatikainen T, Peltonen M, Vartiainen E, Coates MJ, Dunbar JA. Evaluation of AUSDRISK as a screening tool for lifestyle modification programs: international implications for policy and cost-effectiveness. BMJ Open Diabetes Res Care 2015;3:e000125. [PMID: 26468399 DOI: 10.1136/bmjdrc-2015-000125] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
233 Villanueva-sosa LG, Cordero-franco HF, Salinas-martínez AM. Prevalence of Prediabetes Based on Fasting Plasma Glucose and Glycosylated Hemoglobin in an At-Risk Mexican Population. Metabolic Syndrome and Related Disorders 2015;13:352-5. [DOI: 10.1089/met.2015.0040] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
234 Memish ZA, Chang JL, Saeedi MY, Al Hamid MA, Abid O, Ali MK. Screening for Type 2 Diabetes and Dysglycemia in Saudi Arabia: Development and Validation of Risk Scores. Diabetes Technology & Therapeutics 2015;17:693-700. [DOI: 10.1089/dia.2014.0267] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
235 Jagannathan R, Sevick MA, Li H, Fink D, Dankner R, Chetrit A, Roth J, Bergman M. Elevated 1-hour plasma glucose levels are associated with dysglycemia, impaired beta-cell function, and insulin sensitivity: a pilot study from a real world health care setting. Endocrine 2016;52:172-5. [PMID: 26419850 DOI: 10.1007/s12020-015-0746-z] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 5.9] [Reference Citation Analysis]
236 Guthoff M, Vosseler D, Langanke J, Nadalin S, Königsrainer A, Häring HU, Fritsche A, Heyne N. Diabetes Mellitus and Prediabetes on Kidney Transplant Waiting List- Prevalence, Metabolic Phenotyping and Risk Stratification Approach. PLoS One 2015;10:e0134971. [PMID: 26398489 DOI: 10.1371/journal.pone.0134971] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
237 Aekplakorn W, Tantayotai V, Numsangkul S, Sripho W, Tatsato N, Burapasiriwat T, Pipatsart R, Sansom P, Luckanajantachote P, Chawarokorn P, Thanonghan A, Lakhamkaew W, Mungkung A, Boonkean R, Chantapoon C, Kungsri M, Luanseng K, Chaiyajit K. Detecting Prediabetes and Diabetes: Agreement between Fasting Plasma Glucose and Oral Glucose Tolerance Test in Thai Adults. J Diabetes Res 2015;2015:396505. [PMID: 26347060 DOI: 10.1155/2015/396505] [Cited by in Crossref: 18] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
238 Janghorbani M, Almasi SZ, Amini M. The product of triglycerides and glucose in comparison with fasting plasma glucose did not improve diabetes prediction. Acta Diabetol 2015;52:781-8. [PMID: 25572334 DOI: 10.1007/s00592-014-0709-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
239 Salinero-Fort MÁ, de Burgos-Lunar C, Mostaza Prieto J, Lahoz Rallo C, Abánades-Herranz JC, Gómez-Campelo P, Laguna Cuesta F, Estirado De Cabo E, García Iglesias F, González Alegre T, Fernández Puntero B, Montesano Sánchez L, Vicent López D, Cornejo Del Río V, Fernández García PJ, Sabín Rodríguez C, López López S, Patrón Barandío P; SPREDIA-2 Group. Validating prediction scales of type 2 diabetes mellitus in Spain: the SPREDIA-2 population-based prospective cohort study protocol. BMJ Open 2015;5:e007195. [PMID: 26220868 DOI: 10.1136/bmjopen-2014-007195] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
240 Defronzo RA, Ferrannini E, Groop L, Henry RR, Herman WH, Holst JJ, Hu FB, Kahn CR, Raz I, Shulman GI, Simonson DC, Testa MA, Weiss R. Type 2 diabetes mellitus. Nat Rev Dis Primers 2015;1. [DOI: 10.1038/nrdp.2015.19] [Cited by in Crossref: 746] [Cited by in F6Publishing: 788] [Article Influence: 106.6] [Reference Citation Analysis]
241 Kaku K, Kadowaki T, Terauchi Y, Okamoto T, Sato A, Okuyama K, Arjona Ferreira JC, Goldstein BJ. Sitagliptin improves glycaemic excursion after a meal or after an oral glucose load in Japanese subjects with impaired glucose tolerance. Diabetes Obes Metab 2015;17:1033-41. [PMID: 26094974 DOI: 10.1111/dom.12507] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
242 Hannon TS, Kirkman MS, Patel YR, Considine RV, Mather KJ. Profound defects in β-cell function in screen-detected type 2 diabetes are not improved with glucose-lowering treatment in the Early Diabetes Intervention Program (EDIP). Diabetes Metab Res Rev 2014;30:767-76. [PMID: 24819707 DOI: 10.1002/dmrr.2553] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
243 Aroda VR, Getaneh A. Guiding diabetes screening and prevention: rationale, recommendations and remaining challenges. Expert Rev Endocrinol Metab 2015;10:381-98. [PMID: 30293496 DOI: 10.1586/17446651.2015.1054280] [Reference Citation Analysis]
244 Cao L, Sun H, Wu H, Lü Q, Mckee AM; Cochrane Metabolic and Endocrine Disorders Group. Pioglitazone for adults with high risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews. [DOI: 10.1002/14651858.cd011759] [Reference Citation Analysis]
245 Garber AJ. Anti-Obesity Pharmacotherapy and the Potential for Preventing Progression from Prediabetes to Type 2 Diabetes. Endocrine Practice 2015;21:634-44. [DOI: 10.4158/ep14460.ra] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
246 Ghody P, Shikha D, Karam J, Bahtiyar G. Identifying prediabetes – Is it beneficial in the long run? Maturitas 2015;81:282-6. [DOI: 10.1016/j.maturitas.2015.03.022] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
247 Swaleh R, Zeng L, Mbuagbaw L, Morrison KM. Outcomes in the offspring of mothers with pre-diabetes during pregnancy: a protocol for a systematic review. Syst Rev 2015;4:67. [PMID: 25957870 DOI: 10.1186/s13643-015-0051-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
248 Bullard KM, Ali MK, Imperatore G, Geiss LS, Saydah SH, Albu JB, Cowie CC, Sohler N, Albright A, Gregg EW. Receipt of Glucose Testing and Performance of Two US Diabetes Screening Guidelines, 2007-2012. PLoS One 2015;10:e0125249. [PMID: 25928306 DOI: 10.1371/journal.pone.0125249] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
249 Othman A, Saely CH, Muendlein A, Vonbank A, Drexel H, von Eckardstein A, Hornemann T. Plasma 1-deoxysphingolipids are predictive biomarkers for type 2 diabetes mellitus. BMJ Open Diabetes Res Care 2015;3:e000073. [PMID: 25815206 DOI: 10.1136/bmjdrc-2014-000073] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 6.0] [Reference Citation Analysis]
250 Bansal N. Prediabetes diagnosis and treatment: A review. World J Diabetes 2015; 6(2): 296-303 [PMID: 25789110 DOI: 10.4239/wjd.v6.i2.296] [Cited by in CrossRef: 242] [Cited by in F6Publishing: 256] [Article Influence: 34.6] [Reference Citation Analysis]
251 Hosking J, Metcalf BS, Jeffery AN, Streeter AJ, Voss LD, Wilkin TJ. Divergence between HbA1c and fasting glucose through childhood: implications for diagnosis of impaired fasting glucose (Early Bird 52). Pediatr Diabetes 2014;15:214-9. [PMID: 25705748 DOI: 10.1111/pedi.12082] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
252 Ajala O, English P. Dietary Management of Pre-Diabetes and Type 2 Diabetes. Glucose Intake and Utilization in Pre-Diabetes and Diabetes 2015. [DOI: 10.1016/b978-0-12-800093-9.00007-7] [Reference Citation Analysis]
253 D’antona G. Amino Acids Supplementation as Nutritional Therapy Strategy in Diabetes Mellitus. Glucose Intake and Utilization in Pre-Diabetes and Diabetes 2015. [DOI: 10.1016/b978-0-12-800093-9.00032-6] [Reference Citation Analysis]
254 Dall TM, Storm MV, Semilla AP, Wintfeld N, O'Grady M, Narayan KM. Value of lifestyle intervention to prevent diabetes and sequelae. Am J Prev Med 2015;48:271-80. [PMID: 25498548 DOI: 10.1016/j.amepre.2014.10.003] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 3.4] [Reference Citation Analysis]
255 Tamayo T, Schipf S, Meisinger C, Schunk M, Maier W, Herder C, Roden M, Nauck M, Peters A, Völzke H, Rathmann W. Regional differences of undiagnosed type 2 diabetes and prediabetes prevalence are not explained by known risk factors. PLoS One 2014;9:e113154. [PMID: 25402347 DOI: 10.1371/journal.pone.0113154] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
256 Kim JY, Goran MI, Toledo-corral CM, Weigensberg MJ, Shaibi GQ. Comparing glycemic indicators of prediabetes: a prospective study of obese Latino Youth: Predictors of prediabetes in Youth. Pediatr Diabetes 2015;16:640-3. [DOI: 10.1111/pedi.12225] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
257 Kim YA, Ku EJ, Khang AR, Hong ES, Kim KM, Moon JH, Choi SH, Park KS, Jang HC, Lim S. Role of various indices derived from an oral glucose tolerance test in the prediction of conversion from prediabetes to type 2 diabetes. Diabetes Research and Clinical Practice 2014;106:351-9. [DOI: 10.1016/j.diabres.2014.08.014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
258 Sénéchal M, Slaght J, Bharti N, Bouchard DR. Independent and combined effect of diet and exercise in adults with prediabetes. Diabetes Metab Syndr Obes 2014;7:521-9. [PMID: 25382981 DOI: 10.2147/DMSO.S62367] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
259 Buysschaert M, Medina JL, Bergman M, Shah A, Lonier J. Prediabetes and associated disorders. Endocrine 2015;48:371-93. [PMID: 25294012 DOI: 10.1007/s12020-014-0436-2] [Cited by in Crossref: 89] [Cited by in F6Publishing: 73] [Article Influence: 11.1] [Reference Citation Analysis]
260 Alyass A, Almgren P, Akerlund M, Dushoff J, Isomaa B, Nilsson P, Tuomi T, Lyssenko V, Groop L, Meyre D. Modelling of OGTT curve identifies 1 h plasma glucose level as a strong predictor of incident type 2 diabetes: results from two prospective cohorts. Diabetologia. 2015;58:87-97. [PMID: 25292440 DOI: 10.1007/s00125-014-3390-x] [Cited by in Crossref: 90] [Cited by in F6Publishing: 94] [Article Influence: 11.3] [Reference Citation Analysis]
261 Azzouz M, Boudiba A, Guerchani M, Lyes Y, Hannachi R, Baghous H, Meftah A, Mimouni S. Apport du score de risque finlandais FINDRISC dans l’identification de la dysglycémie dans une population algéroise, Algérie. Médecine des Maladies Métaboliques 2014;8:532-538. [DOI: 10.1016/s1957-2557(14)70877-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
262 Harreiter J, Dovjak G, Kautzky-Willer A. Gestational diabetes mellitus and cardiovascular risk after pregnancy. Womens Health (Lond) 2014;10:91-108. [PMID: 24328601 DOI: 10.2217/whe.13.69] [Cited by in Crossref: 52] [Cited by in F6Publishing: 59] [Article Influence: 6.5] [Reference Citation Analysis]
263 Daniele G, Abdul-Ghani M, DeFronzo RA. What are the pharmacotherapy options for treating prediabetes? Expert Opin Pharmacother 2014;15:2003-18. [PMID: 25139488 DOI: 10.1517/14656566.2014.944160] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
264 Geidenstam N, Spégel P, Mulder H, Filipsson K, Ridderstråle M, Danielsson AP. Metabolite profile deviations in an oral glucose tolerance test-a comparison between lean and obese individuals. Obesity (Silver Spring) 2014;22:2388-95. [PMID: 25132155 DOI: 10.1002/oby.20868] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 4.0] [Reference Citation Analysis]
265 Sesti G, Hribal ML, Fiorentino TV, Sciacqua A, Perticone F. Elevated 1 h postload plasma glucose levels identify adults with normal glucose tolerance but increased risk of non-alcoholic fatty liver disease. BMJ Open Diabetes Res Care 2014;2:e000016. [PMID: 25452862 DOI: 10.1136/bmjdrc-2014-000016] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 3.8] [Reference Citation Analysis]
266 Qin G, Lu L, Xiao Y, Zhu Y, Pan W, Xu X, Shen S, Das UN. A cross-sectional study of the relationship between serum liver enzymes level and the incidence of impaired fasting glucose in males and females. Med Sci Monit 2014;20:1319-25. [PMID: 25066107 DOI: 10.12659/MSM.890698] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
267 Cao L, Li J, Wu H, Liu GJ, Dong BR, Lü Q. Pioglitazone for people with impaired glucose tolerance or impaired fasting blood glucose. Cochrane Database of Systematic Reviews 2014. [DOI: 10.1002/14651858.cd009989.pub2] [Reference Citation Analysis]
268 Jeong JY, Kim JG, Kim BW, Moon SS, Kim HS, Park KG, Won KC, Lee HW, Yoon JS, Shon HS, Lee JH, Jung ED, Park MY, Chun BY, Kim KY, Hwang TY, Lee MY, Lee IK. Trend analysis of diabetic prevalence and incidence in a rural area of South Korea between 2003-2008. J Diabetes Investig 2010;1:184-90. [PMID: 24843430 DOI: 10.1111/j.2040-1124.2010.00045.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
269 Winner D, Norton L, Kanat M, Arya R, Fourcaudot M, Hansis-Diarte A, Tripathy D, DeFronzo RA, Jenkinson CP, Abdul-Ghani M. Strong association between insulin-mediated glucose uptake and the 2-hour, not the fasting plasma glucose concentration, in the normal glucose tolerance range. J Clin Endocrinol Metab 2014;99:3444-9. [PMID: 24796924 DOI: 10.1210/jc.2013-2886] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
270 Egidi G. Screening auf Typ-2-Diabetes. Diabetologe 2014;10:223-227. [DOI: 10.1007/s11428-013-1119-y] [Reference Citation Analysis]
271 Wang B, Liu K, Mi M, Wang J. Effect of fruit juice on glucose control and insulin sensitivity in adults: a meta-analysis of 12 randomized controlled trials. PLoS One 2014;9:e95323. [PMID: 24743260 DOI: 10.1371/journal.pone.0095323] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
272 Chandran S, Masharani U, Webber AB, Wojciechowski DM. Prediabetic Living Kidney Donors Have Preserved Kidney Function at 10 Years After Donation. Transplantation 2014;97:748-54. [DOI: 10.1097/01.tp.0000438625.91095.8b] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
273 Sepah SC, Jiang L, Peters AL. Translating the Diabetes Prevention Program into an Online Social Network: Validation against CDC Standards. Diabetes Educ 2014;40:435-43. [DOI: 10.1177/0145721714531339] [Cited by in Crossref: 88] [Cited by in F6Publishing: 92] [Article Influence: 11.0] [Reference Citation Analysis]
274 Ibrahim N, Moy FM, Awalludin IA, Ali Z, Ismail IS. The health-related quality of life among pre-diabetics and its association with body mass index and physical activity in a semi-urban community in Malaysia--a cross sectional study. BMC Public Health 2014;14:298. [PMID: 24684809 DOI: 10.1186/1471-2458-14-298] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
275 Tarasova VD, Caballero JA, Turner P, Inzucchi SE. Speaking to Patients About Diabetes Risk: Is Terminology Important? Clin Diabetes 2014;32:90-5. [PMID: 26130869 DOI: 10.2337/diaclin.32.2.90] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
276 Barber SR, Davies MJ, Khunti K, Gray LJ. Risk assessment tools for detecting those with pre-diabetes: a systematic review. Diabetes Res Clin Pract 2014;105:1-13. [PMID: 24694663 DOI: 10.1016/j.diabres.2014.03.007] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 3.9] [Reference Citation Analysis]
277 Bodicoat DH, Gray LJ, Henson J, Webb D, Guru A, Misra A, Gupta R, Vikram N, Sattar N, Davies MJ. Body mass index and waist circumference cut-points in multi-ethnic populations from the UK and India: the ADDITION-Leicester, Jaipur heart watch and New Delhi cross-sectional studies. PLoS One. 2014;9:e90813. [PMID: 24599391 DOI: 10.1371/journal.pone.0090813] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
278 Fu SN, Luk W, Wong CKH, Cheung KL. Progression from impaired fasting glucose to type 2 diabetes mellitus among Chinese subjects with and without hypertension in a primary care setting 在中国初级保健机构中合并以及不合并高血压的受试者从空腹血糖受损进展到2型糖尿病的调查: Progression of IFG to diabetes. Journal of Diabetes 2014;6:438-46. [DOI: 10.1111/1753-0407.12120] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
279 W Seidel R, Pardo KA, A Estabrooks P, WenYou EY, Wall SS, M Davy B, A Almeida F. Beginning a patient-centered approach in the design of a diabetes prevention program. Int J Environ Res Public Health 2014;11:2003-13. [PMID: 24534767 DOI: 10.3390/ijerph110202003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
280 Schulze MB, Hu FB. Epidemiology of Diabetes. Handbook of Epidemiology 2014. [DOI: 10.1007/978-0-387-09834-0_66] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
281 Cortez M, Singleton JR, Smith AG. Glucose intolerance, metabolic syndrome, and neuropathy. Diabetes and the Nervous System. Elsevier; 2014. pp. 109-22. [DOI: 10.1016/b978-0-444-53480-4.00009-6] [Cited by in Crossref: 28] [Cited by in F6Publishing: 36] [Article Influence: 3.5] [Reference Citation Analysis]
282 Genuth SM. How does pioglitazone prevent progression of impaired glucose tolerance to diabetes? Diabetes 2013;62:3663-5. [PMID: 24158994 DOI: 10.2337/db13-1175] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
283 Marini MA, Frontoni S, Succurro E, Arturi F, Fiorentino TV, Sciacqua A, Hribal ML, Perticone F, Sesti G. Decreased insulin clearance in individuals with elevated 1-h post-load plasma glucose levels. PLoS One 2013;8:e77440. [PMID: 24194886 DOI: 10.1371/journal.pone.0077440] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
284 Du TT, Yin P, Zhang JH, Zhang D, Shi W, Yu XF. Comparison of the performance of HbA1c and fasting plasma glucose in identifying dysglycaemic status in Chinese high-risk subjects. Clin Exp Pharmacol Physiol 2013;40:63-8. [PMID: 23198814 DOI: 10.1111/1440-1681.12038] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
285 Defronzo RA, Tripathy D, Schwenke DC, Banerji M, Bray GA, Buchanan TA, Clement SC, Henry RR, Kitabchi AE, Mudaliar S. Prediction of diabetes based on baseline metabolic characteristics in individuals at high risk. Diabetes Care. 2013;36:3607-3612. [PMID: 24062330 DOI: 10.2337/dc13-0520] [Cited by in Crossref: 41] [Cited by in F6Publishing: 47] [Article Influence: 4.6] [Reference Citation Analysis]
286 Albright AL, Gregg EW. Preventing type 2 diabetes in communities across the U.S.: the National Diabetes Prevention Program. Am J Prev Med 2013;44:S346-51. [PMID: 23498297 DOI: 10.1016/j.amepre.2012.12.009] [Cited by in Crossref: 174] [Cited by in F6Publishing: 183] [Article Influence: 19.3] [Reference Citation Analysis]
287 Ertan C, Ozeke O, Gul M, Aras D, Topaloglu S, Kisacik HL, Demir AD, Aydogdu S, Ozin B. Association of prediabetes with diffuse coronary narrowing and small-vessel disease. J Cardiol 2014;63:29-34. [PMID: 24012434 DOI: 10.1016/j.jjcc.2013.06.015] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
288 Khavandi K, Amer H, Ibrahim B, Brownrigg J. Strategies for preventing type 2 diabetes: an update for clinicians. Ther Adv Chronic Dis. 2013;4:242-261. [PMID: 23997928 DOI: 10.1177/2040622313494986] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
289 Wagner R, Thorand B, Osterhoff MA, Müller G, Böhm A, Meisinger C, Kowall B, Rathmann W, Kronenberg F, Staiger H, Stefan N, Roden M, Schwarz PE, Pfeiffer AF, Häring HU, Fritsche A. Family history of diabetes is associated with higher risk for prediabetes: a multicentre analysis from the German Center for Diabetes Research. Diabetologia 2013;56:2176-80. [PMID: 23979484 DOI: 10.1007/s00125-013-3002-1] [Cited by in Crossref: 41] [Cited by in F6Publishing: 45] [Article Influence: 4.6] [Reference Citation Analysis]
290 Kondo Y, Harada N, Sozu T, Hamasaki A, Yamane S, Muraoka A, Harada T, Shibue K, Nasteska D, Joo E, Sasaki K, Inagaki N. A hospital-based cross-sectional study to develop an estimation formula for 2-h post-challenge plasma glucose for screening impaired glucose tolerance. Diabetes Research and Clinical Practice 2013;101:218-225. [DOI: 10.1016/j.diabres.2013.05.013] [Reference Citation Analysis]
291 Defronzo RA, Tripathy D, Schwenke DC, Banerji M, Bray GA, Buchanan TA, Clement SC, Gastaldelli A, Henry RR, Kitabchi AE, Mudaliar S, Ratner RE, Stentz FB, Musi N, Reaven PD; ACT NOW Study. Prevention of diabetes with pioglitazone in ACT NOW: physiologic correlates. Diabetes 2013;62:3920-6. [PMID: 23863810 DOI: 10.2337/db13-0265] [Cited by in Crossref: 68] [Cited by in F6Publishing: 74] [Article Influence: 7.6] [Reference Citation Analysis]
292 Valensi P, Cosson E. Identification of Target Populations for Intervention. Prevention of Diabetes 2013. [DOI: 10.1002/9781118661321.ch2] [Reference Citation Analysis]
293 Liu K, Zhou R, Wang B, Chen K, Shi LY, Zhu JD, Mi MT. Effect of green tea on glucose control and insulin sensitivity: a meta-analysis of 17 randomized controlled trials. Am J Clin Nutr. 2013;98:340-348. [PMID: 23803878 DOI: 10.3945/ajcn.112.052746] [Cited by in Crossref: 108] [Cited by in F6Publishing: 111] [Article Influence: 12.0] [Reference Citation Analysis]
294 Buckley CM, Madden J, Balanda K, Barron S, Fahy L, Harrington J, Perry IJ, M. Kearney P. Pre-diabetes in adults 45 years and over in Ireland: the Survey of Lifestyle, Attitudes and Nutrition in Ireland 2007. Diabet Med 2013;30:1198-203. [DOI: 10.1111/dme.12226] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
295 Strandberg AY, Pienimäki T, Pitkälä KH, Tilvis RS, Salomaa VV, Strandberg TE. Comparison of normal fasting and one-hour glucose levels as predictors of future diabetes during a 34-year follow-up. Ann Med. 2013;45:336-340. [PMID: 23688029 DOI: 10.3109/07853890.2013.785233] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
296 Choukem S, Mbanya J. Should we still screen for type 2 diabetes after ADDITION-Cambridge? A low-income world perspective. Diabetes Research and Clinical Practice 2013;100:282-284. [DOI: 10.1016/j.diabres.2013.01.025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
297 Andersson S, Ekman I, Friberg F, Daka B, Lindblad U, Larsson CA. The association between self-rated health and impaired glucose tolerance in Swedish adults: a cross-sectional study. Scand J Prim Health Care 2013;31:111-8. [PMID: 23621319 DOI: 10.3109/02813432.2013.784541] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
298 Morris DH, Khunti K, Achana F, Srinivasan B, Gray LJ, Davies MJ, Webb D. Progression rates from HbA1c 6.0-6.4% and other prediabetes definitions to type 2 diabetes: a meta-analysis. Diabetologia. 2013;56:1489-1493. [PMID: 23584433 DOI: 10.1007/s00125-013-2902-4] [Cited by in Crossref: 143] [Cited by in F6Publishing: 140] [Article Influence: 15.9] [Reference Citation Analysis]
299 McEwen LN, Adams SR, Schmittdiel JA, Ferrara A, Selby JV, Herman WH. Screening for impaired fasting glucose and diabetes using available health plan data. J Diabetes Complications 2013;27:580-7. [PMID: 23587840 DOI: 10.1016/j.jdiacomp.2013.01.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
300 Tziomalos K, Spanou M, Baltatzi M, Efthymiou E, Psianou K, Papastergiou N, Iliadis F, Didangelos TP, Savopoulos C, Hatzitolios AI. Impaired fasting glucose in hypertensive patients: prevalence and cross-sectional analysis of associations with cardiovascular disease. Diabetes Technol Ther 2013;15:475-80. [PMID: 23544673 DOI: 10.1089/dia.2012.0336] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
301 Eikenberg JD, Davy BM. Prediabetes: a prevalent and treatable, but often unrecognized, clinical condition. J Acad Nutr Diet 2013;113:213-8. [PMID: 23351624 DOI: 10.1016/j.jand.2012.10.018] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
302 Kim JY, Goran MI, Toledo-Corral CM, Weigensberg MJ, Choi M, Shaibi GQ. One-hour glucose during an oral glucose challenge prospectively predicts β-cell deterioration and prediabetes in obese Hispanic youth. Diabetes Care 2013;36:1681-6. [PMID: 23315601 DOI: 10.2337/dc12-1861] [Cited by in Crossref: 23] [Cited by in F6Publishing: 1] [Article Influence: 2.6] [Reference Citation Analysis]
303 Kim JY, Goran MI, Toledo-Corral CM, Weigensberg MJ, Choi M, Shaibi GQ. One-hour glucose during an oral glucose challenge prospectively predicts β-cell deterioration and prediabetes in obese Hispanic youth. Diabetes Care 2013;36:1681-6. [PMID: 23315601 DOI: 10.2337/dc12-1861] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
304 Nah EH, Cho H. Association of Blood Homocysteine levels with Subclinical Atherosclerosis in Impaired Fasting Glucose. Lab Med Online 2013;3:213. [DOI: 10.3343/lmo.2013.3.4.213] [Reference Citation Analysis]
305 Xia Q, Chen ZX, Wang YC, Ma YS, Zhang F, Che W, Fu D, Wang XF. Association between the melatonin receptor 1B gene polymorphism on the risk of type 2 diabetes, impaired glucose regulation: a meta-analysis. PLoS One. 2012;7:e50107. [PMID: 23226241 DOI: 10.1371/journal.pone.0050107] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 3.4] [Reference Citation Analysis]
306 Ang YG, WU CX, Toh MP, Chia KS, Heng BH. Progression rate of newly diagnosed impaired fasting glycemia to type 2 diabetes mellitus: a study using the National Healthcare Group Diabetes Registry in Singapore. J Diabetes 2012;4:159-63. [PMID: 22059651 DOI: 10.1111/j.1753-0407.2011.00169.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
307 Armato J, DeFronzo RA, Abdul-Ghani M, Ruby R. Successful treatment of prediabetes in clinical practice: targeting insulin resistance and β-cell dysfunction. Endocr Pract. 2012;18:342-350. [PMID: 22068250 DOI: 10.4158/ep11194.or] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
308 Echouffo-Tcheugui JB, Mayige M, Ogbera AO, Sobngwi E, Kengne AP. Screening for hyperglycemia in the developing world: rationale, challenges and opportunities. Diabetes Res Clin Pract 2012;98:199-208. [PMID: 22975016 DOI: 10.1016/j.diabres.2012.08.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
309 Vassy JL, Meigs JB. Is genetic testing useful to predict type 2 diabetes? Best Pract Res Clin Endocrinol Metab. 2012;26:189-201. [PMID: 22498248 DOI: 10.1016/j.beem.2011.09.002] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 4.2] [Reference Citation Analysis]
310 Intzilakis T, Mouridsen MR, Almdal TP, Haugaard SB, Sajadieh A. Impaired fasting glucose in combination with silent myocardial ischaemia is associated with poor prognosis in healthy individuals: Silent myocardial ischaemia and elevated glucose. Diabetic Medicine 2012;29:e163-9. [DOI: 10.1111/j.1464-5491.2012.03639.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
311 Cao L, Li J, Wu H, Liu GJ, Dong BR, Lü Q. Pioglitazone for people with impaired glucose tolerance or impaired fasting blood glucose. Cochrane Database of Systematic Reviews 2012. [DOI: 10.1002/14651858.cd009989] [Reference Citation Analysis]
312 Souza CFD, Gross JL, Gerchman F, Leitão CB. Pré-diabetes: diagnóstico, avaliação de complicações crônicas e tratamento. Arq Bras Endocrinol Metab 2012;56:275-84. [DOI: 10.1590/s0004-27302012000500001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
313 Yakubovich N, Gerstein HC. Is regression to normoglycaemia clinically important? Lancet. 2012;379:2216-2218. [PMID: 22683127 DOI: 10.1016/s0140-6736(12)60828-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
314 Tabák AG, Herder C, Rathmann W, Brunner EJ, Kivimäki M. Prediabetes: a high-risk state for diabetes development. Lancet. 2012;379:2279-2290. [PMID: 22683128 DOI: 10.1016/s0140-6736(12)60283-9] [Cited by in Crossref: 1388] [Cited by in F6Publishing: 1478] [Article Influence: 138.8] [Reference Citation Analysis]
315 Kubicky RA, Dunne C, Nandi-Munshi D, De Luca F. Long-term effects of a non-intensive weight program on body mass index and metabolic abnormalities of obese children and adolescents. Int J Pediatr Endocrinol 2012;2012:16. [PMID: 22682162 DOI: 10.1186/1687-9856-2012-16] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
316 Furtado de Souza C, Dalzochio MB, de Oliveira FJ, Gross JL, Leitão CB. Glucose tolerance status is a better predictor of diabetes and cardiovascular outcomes than metabolic syndrome: a prospective cohort study. Diabetol Metab Syndr 2012;4:25. [PMID: 22682107 DOI: 10.1186/1758-5996-4-25] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
317 American Association of Diabetes Educators. Primary prevention of type 2 diabetes. Diabetes Educ 2012;38:147-50. [PMID: 22328043 DOI: 10.1177/0145721711431926] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
318 Dejager S, Schweizer A, Foley JE. Evidence to support the use of vildagliptin monotherapy in the treatment of type 2 diabetes mellitus. Vasc Health Risk Manag 2012;8:339-48. [PMID: 22661900 DOI: 10.2147/VHRM.S31758] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
319 Willems SM, Mihaescu R, Sijbrands EJ, van Duijn CM, Janssens AC. A methodological perspective on genetic risk prediction studies in type 2 diabetes: recommendations for future research. Curr Diab Rep 2011;11:511-8. [PMID: 21947855 DOI: 10.1007/s11892-011-0235-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
320 Narayan KM, Echouffo-Tcheugui JB, Mohan V, Ali MK. Analysis & commentary: Global prevention and control of type 2 diabetes will require paradigm shifts in policies within and among countries. Health Aff (Millwood) 2012;31:84-92. [PMID: 22232098 DOI: 10.1377/hlthaff.2011.1040] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 2.6] [Reference Citation Analysis]
321 Robertson C. The role of the nurse practitioner in the diagnosis and early management of type 2 diabetes: Role of the NP in the diagnosis and early management of T2D. Journal of the American Academy of Nurse Practitioners 2012;24:225-33. [DOI: 10.1111/j.1745-7599.2012.00719.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
322 Luitse MJ, Biessels GJ, Rutten GE, Kappelle LJ. Diabetes, hyperglycaemia, and acute ischaemic stroke. Lancet Neurol. 2012;11:261-271. [PMID: 22341034 DOI: 10.1016/s1474-4422(12)70005-4] [Cited by in Crossref: 277] [Cited by in F6Publishing: 298] [Article Influence: 27.7] [Reference Citation Analysis]
323 Tolkacheva VV, Villevalde SV, Kobalava ZD. Carbohydrate metabolism and transformation of pre-diabetes into type 2 diabetes mellitus depending on diagnostic methods in nondiabetic patients with hypertension and high cardiovascular risk. Arter gipertenz 2012;18:83-95. [DOI: 10.18705/1607-419x-2012-18-2-83-95] [Reference Citation Analysis]
324 Nomura K, Inoue K, Akimoto K. A two-step screening, measurement of HbA1c in association with FPG, may be useful in predicting diabetes. PLoS One 2012;7:e36309. [PMID: 22558430 DOI: 10.1371/journal.pone.0036309] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
325 Echouffo-Tcheugui JB, Dagogo-Jack S. Preventing diabetes mellitus in developing countries. Nat Rev Endocrinol 2012;8:557-62. [PMID: 22488646 DOI: 10.1038/nrendo.2012.46] [Cited by in Crossref: 25] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
326 Kolberg JA, Gerwien RW, Watkins SM, Wuestehube LJ, Urdea M. Biomarkers in Type 2 diabetes: improving risk stratification with the PreDx ® Diabetes Risk Score. Expert Rev Mol Diagn 2011;11:775-92. [PMID: 22022939 DOI: 10.1586/erm.11.63] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
327 Grundy SM. Pre-diabetes, metabolic syndrome, and cardiovascular risk. J Am Coll Cardiol. 2012;59:635-643. [PMID: 22322078 DOI: 10.1016/j.jacc.2011.08.080] [Cited by in Crossref: 381] [Cited by in F6Publishing: 407] [Article Influence: 38.1] [Reference Citation Analysis]
328 Kanat M, Mari A, Norton L, Winnier D, DeFronzo RA, Jenkinson C, Abdul-Ghani MA. Distinct β-cell defects in impaired fasting glucose and impaired glucose tolerance. Diabetes. 2012;61:447-453. [PMID: 22275086 DOI: 10.2337/db11-0995] [Cited by in Crossref: 83] [Cited by in F6Publishing: 88] [Article Influence: 8.3] [Reference Citation Analysis]
329 van der Zijl NJ, Moors CCM, Goossens GH, Blaak EE, Diamant M. Does interference with the renin-angiotensin system protect against diabetes? Evidence and mechanisms. Diabetes, Obesity and Metabolism 2012;14:586-95. [DOI: 10.1111/j.1463-1326.2012.01559.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
330 Janghorbani M, Amini M. Normal fasting plasma glucose and risk of prediabetes and type 2 diabetes: the Isfahan Diabetes Prevention Study. Rev Diabet Stud 2011;8:490-8. [PMID: 22580730 DOI: 10.1900/RDS.2011.8.490] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
331 Kontogianni MD, Liatis S, Grammatikou S, Perrea D, Katsilambros N, Makrilakis K. Changes in dietary habits and their association with metabolic markers after a non-intensive, community-based lifestyle intervention to prevent type 2 diabetes, in Greece. The DEPLAN study. Diabetes Research and Clinical Practice 2012;95:207-14. [DOI: 10.1016/j.diabres.2011.09.010] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
332 Morrison KM, Xu L, Tarnopolsky M, Yusuf Z, Atkinson SA, Yusuf S. Screening for dysglycemia in overweight youth presenting for weight management. Diabetes Care 2012;35:711-6. [PMID: 22271926 DOI: 10.2337/dc11-1659] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
333 Albright A, Williamson D. Community Approaches to Diabetes Prevention. Prevention of Type 2 Diabetes 2012. [DOI: 10.1007/978-1-4614-3314-9_12] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
334 Ali MK, Echouffo-tcheugui JB, Williamson DF. How Effective Were Lifestyle Interventions In Real-World Settings That Were Modeled On The Diabetes Prevention Program? Health Affairs 2012;31:67-75. [DOI: 10.1377/hlthaff.2011.1009] [Cited by in Crossref: 387] [Cited by in F6Publishing: 403] [Article Influence: 38.7] [Reference Citation Analysis]
335 Schulze M, Kowall B, Rathmann W. Biomarker und Risikoprädiktion des Typ-2-Diabetes. Diabetologe 2012;8:18-25. [DOI: 10.1007/s11428-011-0776-y] [Reference Citation Analysis]
336 Tocci G, Ferrucci A, Passerini J, Averna M, Bellotti P, Bruno G, Cosentino F, Crepaldi G, Giannattasio C, Modena MG, Nati G, Tiengo A, Trimarco B, Vanuzzo D, Volpe M. Prevalence of 'borderline' values of cardiovascular risk factors in the clinical practice of general medicine in Italy: results of the BORDERLINE study. High Blood Press Cardiovasc Prev 2011;18:43-51. [PMID: 21806078 DOI: 10.2165/11593420-000000000-00000] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
337 Fu C, Chen Y, Wang F, Wang X, Song J, Jiang Q. High prevalence of hyperglycaemia and the impact of high household income in transforming rural China. BMC Public Health 2011;11:862. [PMID: 22078718 DOI: 10.1186/1471-2458-11-862] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
338 Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus--present and future perspectives. Nat Rev Endocrinol. 2011;8:228-236. [PMID: 22064493 DOI: 10.1038/nrendo.2011.183] [Cited by in Crossref: 1263] [Cited by in F6Publishing: 1353] [Article Influence: 114.8] [Reference Citation Analysis]
339 Bloomgarden ZT. Insulin concerns and promises. Diabetes Care 2011;34:e100-6. [PMID: 21617099 DOI: 10.2337/dc11-0591] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
340 Ackermann RT, Finch EA, Caffrey HM, Lipscomb ER, Hays LM, Saha C. Long-term effects of a community-based lifestyle intervention to prevent type 2 diabetes: the DEPLOY extension pilot study. Chronic Illness 2011;7:279-90. [DOI: 10.1177/1742395311407532] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 3.8] [Reference Citation Analysis]
341 DeFronzo RA, Abdul-Ghani M. Assessment and treatment of cardiovascular risk in prediabetes: impaired glucose tolerance and impaired fasting glucose. Am J Cardiol 2011;108:3B-24B. [PMID: 21802577 DOI: 10.1016/j.amjcard.2011.03.013] [Cited by in Crossref: 202] [Cited by in F6Publishing: 219] [Article Influence: 18.4] [Reference Citation Analysis]
342 Abdul-Ghani MA, Abdul-Ghani T, Stern MP, Karavic J, Tuomi T, Bo I, Defronzo RA, Groop L. Two-step approach for the prediction of future type 2 diabetes risk. Diabetes Care 2011;34:2108-12. [PMID: 21788628 DOI: 10.2337/dc10-2201] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
343 Nasr G, Sliem H. Silent myocardial ischemia in prediabetics in relation to insulin resistance. J Cardiovasc Dis Res 2010;1:116-21. [PMID: 21187864 DOI: 10.4103/0975-3583.70903] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
344 Heianza Y, Hara S, Arase Y, Saito K, Fujiwara K, Tsuji H, Kodama S, Hsieh SD, Mori Y, Shimano H. HbA1c 5.7-6.4% and impaired fasting plasma glucose for diagnosis of prediabetes and risk of progression to diabetes in Japan (TOPICS 3): a longitudinal cohort study. Lancet. 2011;378:147-155. [PMID: 21705064 DOI: 10.1016/s0140-6736(11)60472-8] [Cited by in Crossref: 163] [Cited by in F6Publishing: 174] [Article Influence: 14.8] [Reference Citation Analysis]
345 Viera AJ. Predisease: when does it make sense? Epidemiol Rev 2011;33:122-34. [PMID: 21624963 DOI: 10.1093/epirev/mxr002] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 3.1] [Reference Citation Analysis]
346 Echouffo-Tcheugui JB, Ali MK, Griffin SJ, Narayan KM. Screening for type 2 diabetes and dysglycemia. Epidemiol Rev 2011;33:63-87. [PMID: 21624961 DOI: 10.1093/epirev/mxq020] [Cited by in Crossref: 53] [Cited by in F6Publishing: 58] [Article Influence: 4.8] [Reference Citation Analysis]
347 Robinson CA, Abdel-Motagally M. Comment on: Zhang et al. A1C level and future risk of diabetes: a systematic review. Diabetes Care 2010;33:1665-1673. Diabetes Care 2011;34:e20; author reply e21. [PMID: 21270178 DOI: 10.2337/dc10-1901] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
348 Tfayli H, Lee SJ, Bacha F, Arslanian S. One-hour plasma glucose concentration during the OGTT: what does it tell about β-cell function relative to insulin sensitivity in overweight/obese children? Pediatr Diabetes 2011;12:572-9. [PMID: 21466647 DOI: 10.1111/j.1399-5448.2011.00745.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 25] [Article Influence: 0.9] [Reference Citation Analysis]
349 Ackermann RT, Cheng YJ, Williamson DF, Gregg EW. Identifying adults at high risk for diabetes and cardiovascular disease using hemoglobin A1c National Health and Nutrition Examination Survey 2005-2006. Am J Prev Med 2011;40:11-7. [PMID: 21146762 DOI: 10.1016/j.amepre.2010.09.022] [Cited by in Crossref: 76] [Cited by in F6Publishing: 82] [Article Influence: 6.9] [Reference Citation Analysis]
350 Napoli N, Costanza F, Di Stasio E, Strollo R, Manfrini S, Cipponeri E, Picardi A, Carrano F, Dell'Anna V, Macino W, Pozzilli P. Blood glucose monitoring in the normal population: the PREDICA study. Acta Diabetol 2011;48:29-34. [PMID: 20703502 DOI: 10.1007/s00592-010-0212-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
351 Wan Q, Wang F, Wang F, Guan Q, Liu Y, Wang C, Feng L, Gao G, Gao L, Zhao J. Regression to normoglycaemia by fenofibrate in pre-diabetic subjects complicated with hypertriglyceridaemia: a prospective randomized controlled trial. Diabet Med 2010;27:1312-7. [PMID: 20968112 DOI: 10.1111/j.1464-5491.2010.03107.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
352 Westerhaus B, Gosmanov AR, Umpierrez GE. Diabetes prevention: can insulin secretagogues do the job? Prim Care Diabetes 2011;5:73-80. [PMID: 21185798 DOI: 10.1016/j.pcd.2010.11.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
353 Volpe M, Borghi C, Cavallo Perin P, Chiariello M, Manzato E, Miccoli R, Modena MG, Riccardi G, Sesti G, Tiengo A, Trimarco B, Vanuzzo D, Verdecchia P, Zaninelli A, Del Prato S. 2009 SIPREC Consensus Document – Executive Summary. High Blood Pressure & Cardiovascular Prevention 2010;17:237-247. [DOI: 10.2165/11311990-000000000-00000] [Reference Citation Analysis]
354 Palermo A, Napoli N, Manfrini S, Lauria A, Strollo R, Pozzilli P. Buccal spray insulin in subjects with impaired glucose tolerance: the prevoral study. Diabetes, Obesity and Metabolism 2011;13:42-6. [DOI: 10.1111/j.1463-1326.2010.01312.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
355 Xu M, Bi Y, Xu Y, Yu B, Huang Y, Gu L, Wu Y, Zhu X, Li M, Wang T, Song A, Hou J, Li X, Ning G. Combined effects of 19 common variations on type 2 diabetes in Chinese: results from two community-based studies. PLoS One 2010;5:e14022. [PMID: 21103332 DOI: 10.1371/journal.pone.0014022] [Cited by in Crossref: 66] [Cited by in F6Publishing: 70] [Article Influence: 5.5] [Reference Citation Analysis]
356 Boyle JP, Thompson TJ, Gregg EW, Barker LE, Williamson DF. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metr 2010;8:29. [PMID: 20969750 DOI: 10.1186/1478-7954-8-29] [Cited by in Crossref: 824] [Cited by in F6Publishing: 1] [Article Influence: 68.7] [Reference Citation Analysis]
357 Boyle JP, Thompson TJ, Gregg EW, Barker LE, Williamson DF. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metr. 2010;8:29. [PMID: 20969750 DOI: 10.1186/1478-7954-8-29] [Cited by in Crossref: 868] [Cited by in F6Publishing: 934] [Article Influence: 72.3] [Reference Citation Analysis]
358 Zhang X, Gregg EW, Williamson DF, Barker LE, Thomas W, Bullard KM, Imperatore G, Williams DE, Albright AL. A1C level and future risk of diabetes: a systematic review. Diabetes Care. 2010;33:1665-1673. [PMID: 20587727 DOI: 10.2337/dc09-1939] [Cited by in Crossref: 239] [Cited by in F6Publishing: 251] [Article Influence: 19.9] [Reference Citation Analysis]
359 Escobedo J, Chavira I, Martínez L, Velasco X, Escandón C, Cabral J. Diabetes and other glucose metabolism abnormalities in Mexican Zapotec and Mixe Indians. Diabet Med 2010;27:412-6. [PMID: 20536512 DOI: 10.1111/j.1464-5491.2010.02966.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
360 Scheen A, Luyckx F. L’hyperglycémie provoquée par voie orale (HGPO) revisitée. Médecine des Maladies Métaboliques 2010;4:569-574. [DOI: 10.1016/s1957-2557(10)70124-3] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
361 Cosson E, Hamo-tchatchouang E, Banu I, Nguyen M, Chiheb S, Ba H, Valensi P. A large proportion of prediabetes and diabetes goes undiagnosed when only fasting plasma glucose and/or HbA1c are measured in overweight or obese patients. Diabetes & Metabolism 2010;36:312-8. [DOI: 10.1016/j.diabet.2010.02.004] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
362 Nasr G, Sliem H. Silent ischemia in relation to insulin resistance in normotensive prediabetic adults: early detection by single photon emission computed tomography (SPECT). Int J Cardiovasc Imaging 2011;27:335-41. [PMID: 20730497 DOI: 10.1007/s10554-010-9682-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
363 Bartoli E, Fra GP, Carnevale Schianca GP. The oral glucose tolerance test (OGTT) revisited. Eur J Intern Med. 2011;22:8-12. [PMID: 21238885 DOI: 10.1016/j.ejim.2010.07.008] [Cited by in Crossref: 113] [Cited by in F6Publishing: 118] [Article Influence: 9.4] [Reference Citation Analysis]
364 Ali MK, Weber MB, Narayan KMV. The Global Burden of Diabetes. In: Holt RIG, Cockram CS, Flyvbjerg A, Goldstein BJ, editors. Textbook of Diabetes. Oxford: Wiley-Blackwell; 2010. pp. 69-84. [DOI: 10.1002/9781444324808.ch5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
365 Rathmann W, Strassburger K, Heier M, Holle R, Thorand B, Giani G, Meisinger C. Incidence of Type 2 diabetes in the elderly German population and the effect of clinical and lifestyle risk factors: KORA S4/F4 cohort study. Diabet Med. 2009;26:1212-1219. [PMID: 20002472 DOI: 10.1111/j.1464-5491.2009.02863.x] [Cited by in Crossref: 129] [Cited by in F6Publishing: 131] [Article Influence: 10.8] [Reference Citation Analysis]
366 Lü Q, Ke L-, Tong N, Cao L, Wu T, Zhang J; Cochrane Metabolic and Endocrine Disorders Group. Metformin for people with impaired glucose tolerance or impaired fasting blood glucose. Cochrane Database of Systematic Reviews. [DOI: 10.1002/14651858.cd008558] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
367 Gerstein HC. More insights on the dysglycaemia–cardiovascular connection. The Lancet 2010;375:2195-6. [DOI: 10.1016/s0140-6736(10)60973-7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
368 Volpe M, Borghi C, Cavallo Perin P, Chiariello M, Manzato E, Miccoli R, Modena MG, Riccardi G, Sesti G, Tiengo A, Trimarco B, Vanuzzo D, Verdecchia P, Zaninelli A, Del Prato S. Cardiovascular Prevention in Subjects with Impaired Fasting Glucose or Impaired Glucose Tolerance: . High Blood Pressure & Cardiovascular Prevention 2010;17:73-102. [DOI: 10.2165/11311830-000000000-00000] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
369 Gautier A, Roussel R, Ducluzeau PH, Lange C, Vol S, Balkau B, Bonnet F; DESIR Study Group. Increases in waist circumference and weight as predictors of type 2 diabetes in individuals with impaired fasting glucose: influence of baseline BMI: data from the DESIR study. Diabetes Care 2010;33:1850-2. [PMID: 20484131 DOI: 10.2337/dc10-0368] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 3.3] [Reference Citation Analysis]
370 Preiss D, Welsh P, Murray HM, Shepherd J, Packard C, Macfarlane P, Cobbe S, Ford I, Sattar N. Fasting plasma glucose in non-diabetic participants and the risk for incident cardiovascular events, diabetes, and mortality: results from WOSCOPS 15-year follow-up. Eur Heart J 2010;31:1230-6. [PMID: 20395260 DOI: 10.1093/eurheartj/ehq095] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
371 Abdul-Ghani MA, DeFronzo RA. Plasma glucose concentration and prediction of future risk of type 2 diabetes. Diabetes Care. 2009;32 Suppl 2:S194-S198. [PMID: 19875551 DOI: 10.2337/dc09-s309] [Cited by in Crossref: 83] [Cited by in F6Publishing: 88] [Article Influence: 6.9] [Reference Citation Analysis]
372 Abdul-Ghani MA, Stern MP, Lyssenko V, Tuomi T, Groop L, Defronzo RA. Minimal contribution of fasting hyperglycemia to the incidence of type 2 diabetes in subjects with normal 2-h plasma glucose. Diabetes Care. 2010;33:557-561. [PMID: 20007945 DOI: 10.2337/dc09-1145] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 3.1] [Reference Citation Analysis]
373 American Association of Diabetes Ed. AADE Position Statement. Diabetes Educ 2009;35:57S-9S. [DOI: 10.1177/0145721709339141] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
374 Kolberg JA, Jørgensen T, Gerwien RW, Hamren S, McKenna MP, Moler E, Rowe MW, Urdea MS, Xu XM, Hansen T. Development of a type 2 diabetes risk model from a panel of serum biomarkers from the Inter99 cohort. Diabetes Care. 2009;32:1207-1212. [PMID: 19564473 DOI: 10.2337/dc08-1935] [Cited by in Crossref: 122] [Cited by in F6Publishing: 130] [Article Influence: 9.4] [Reference Citation Analysis]
375 Zimmet P. Preventing diabetic complications: a primary care perspective. Diabetes Res Clin Pract 2009;84:107-16. [PMID: 19278746 DOI: 10.1016/j.diabres.2009.01.016] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
376 Rambod M, Hosseinpanah F, Ardakani EM, Padyab M, Azizi F. Fine-tuning of prediction of isolated impaired glucose tolerance: a quantitative clinical prediction model. Diabetes Res Clin Pract 2009;83:61-8. [PMID: 19012984 DOI: 10.1016/j.diabres.2008.09.040] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
377 Aroda VR, Ratner R. Approach to the Patient with Prediabetes. The Journal of Clinical Endocrinology & Metabolism 2008;93:3259-65. [DOI: 10.1210/jc.2008-1091] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 3.5] [Reference Citation Analysis]
378 Tomlinson JW, Finney J, Gay C, Hughes BA, Hughes SV, Stewart PM. Impaired glucose tolerance and insulin resistance are associated with increased adipose 11beta-hydroxysteroid dehydrogenase type 1 expression and elevated hepatic 5alpha-reductase activity. Diabetes. 2008;57:2652-2660. [PMID: 18633104 DOI: 10.2337/db08-0495] [Cited by in Crossref: 101] [Cited by in F6Publishing: 108] [Article Influence: 7.2] [Reference Citation Analysis]
379 John Wiley & Sons, Ltd. Current literature in diabetes. Diabetes Metab Res Rev 2008;24:i-x. [DOI: 10.1002/dmrr.887] [Reference Citation Analysis]
380 Li G, Zhang P, Wang J, Gregg EW, Yang W, Gong Q, Li H, Li H, Jiang Y, An Y, Shuai Y, Zhang B, Zhang J, Thompson TJ, Gerzoff RB, Roglic G, Hu Y, Bennett PH. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet. 2008;371:1783-1789. [PMID: 18502303 DOI: 10.1016/s0140-6736(08)60766-7] [Cited by in Crossref: 1044] [Cited by in F6Publishing: 1100] [Article Influence: 74.6] [Reference Citation Analysis]
381 Wild RA. Pioglitazone and metformin for increased small low-density lipoprotein in polycystic ovary syndrome: counterpoint. Am J Obstet Gynecol 2008;198:4-6. [PMID: 18166296 DOI: 10.1016/j.ajog.2007.09.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]